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The ten-eleven translocation proteins TET1, TET2, and TET3 mediate oxidation 
of the modified base 5-methylcytosine (5mC) to 5-hydroxymethylcytosine 
(5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) through an 
iterative process. Oxidation of 5mC has been suggested to play the first step in 
DNA demethylation pathways. However, the functions of TET proteins in 
promoting vertebrate development and differentiation have not been fully defined. 
To systematically assess the requirements for TET proteins during development, 
we mutated the zebrafish orthologs of TET1, TET2, and TET3, and examined 
single, double and triple mutant genotypes. Using these mutant lines, we 
identified Tet2 and Tet3 as the major 5-methylcytosine dioxygenases in the 
zebrafish embryo. In addition, we have uncovered overlapping requirements for 
Tet2 and Tet3 in hematopoietic stem cell (HSC) development. Our results identify 
Tet2 and Tet3 as early regulators of the notch signaling required for induction of 
the hematopoietic transcription factor program in the hemogenic endothelium. 
These studies have also revealed a potential link between inflammatory signaling 
from the primitive hematopoietic system and defective notch signaling in tet2/3 
mutants.  Further study revealed that enhanced Tet1 activity could compensate 
  
the loss for Tet2/3 during HSC emergence, providing evidence that members of 
TET family behave similarly and can act interchangeably when expressed at 
sufficient levels. Lastly, we discuss applications of the tet2/3DM platform to 
identifying novel regulators of TET proteins. Collectively, this research defines 
essential, overlapping functions for TET proteins during embryonic development 
and uncovers a requirement for 5hmC in regulating HSC emergence. 
Additionally, the findings, as well as the tet2/3 double mutant larvae we 
generated, hold great promise to facilitate the study of blood cancer treatment. 
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CHAPTER ONE: INTRODUCTION 
 
 
Section 1. Oxidation of 5-methylcytosine by the ten-eleven translocation 
(TET) proteins 
 
 
1.1 5-methylctyosine 
 
Methylation of DNA at the 5’ position of the cytosine ring (5mC) represents a 
conserved modification contributing to transcriptional repression. This 
modification is essential for normal vertebrate development (Goll & Bestor, 
2005). DNA methylation has critical roles in controlling gene expression, 
ensuring X-chromosome inactivation and reinforcing genomic imprinting 
(Jaenisch & Bird, 2003; Smith & Meissner, 2013). Aberrant DNA methylation 
is also observed in many diseases including cancer. In vertebrates, DNA 
methylation is primarily restricted to symmetrical CpG dinucleotides, which 
are extensively methylated across the genome. An exception is CpG islands, 
which are typically unmethylated. These CpG islands represent less than 
10% of the total genomic CpG content and are prevalent at transcription start 
sites of developmentally regulated genes (Smith & Meissner, 2013). 
Abnormal gains in 5mC in normally unmethylated CpG islands have been 
linked to the inactivation of tumor suppressor genes in many cancers (Zhu, 
Wang, & Qian, 2016). However, the mechanism by which 5mC becomes 
abnormally accumulated at the regulatory regions in cancers remains unclear. 
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A better understanding of how 5mC is regulated is of particular importance in 
understanding normal development and the pathogenesis of diseases. 
 
 
The DNA methylation reaction is executed by two groups of DNA 
methyltransferases: the maintenance methyltransferase, DNMT1, and the de 
novo methyltransferases of the DNMT3 family (Denis, Ndlovu, & Fuks, 2011). 
De novo methyltransferases methylate unmodified DNA to establish 
methylation patterns. During maintenance of DNA methylation, the cofactor 
UHRF1 recruits DNMT1 to hemimethylated CpG dinucleotides at the 
replication fork, allowing faithful propagation of methylation patterns to the 
newly synthesized DNA strand (Bostick et al., 2007; Sharif et al., 2007). The 
orchestration of de novo and maintenance DNA methylation enables the 
heritability of 5mC patterns throughout the development of the organism. 
 
 
 
1.2 TET proteins catalyze oxidation of 5-methylcytosine 
 
For many years, 5mC was thought to be the only modified DNA base in the 
mammalian genome. However, in 2009, two groups reported the presence of 
the 5-hydroxymethylcytosine (5hmC), an oxidative derivative of 5mC, in 
mammalian DNA (Kriaucionis & Heintz, 2009; Tahiliani et al., 2009). 
Subsequent studies have demonstrated that the ten-eleven translocation 
proteins (TET1, TET2 and TET3) oxidize 5mC to 5hmC and that they are 
capable of further oxidation of 5hmC to 5-formylcytosine (5fC) and 5- 
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carboxylcytosine (5caC) through an iterative process (Tahiliani et al., 2009; H. 
Wu & Zhang, 2011). These novel modified bases may represent new 
epigenetic states in the genome. Insights into the functions of the 5mC- 
oxidized products and how TET proteins regulate the oxidation process will 
greatly enhance our understanding of epigenetic regulation of normal 
development and diseases. 
 
 
 
1.3 TET protein structure and activity 
 
TET1 was first identified as a fusion partner of mixed-lineage leukemia (MLL), 
resulting from the chromosomal translocation t(10;11)(q22;23) in acute 
leukemia (Lorsbach et al., 2003; Ono et al., 2002). TET proteins have been 
subsequently identified as a family of large multidomain enzymes containing a 
conserved double-stranded β-helix (DSBH) domain, a cysteine-rich domain 
and cofactors Fe (II) and 2-oxoglutarate (2-OG) binding domains. Mammalian 
genomes encode for three TET genes (TET1, TET2 and TET3). In addition to 
the catalytic domain, TET1 and TET3 contain an N-terminal CXXC zinc finger 
domain, allowing them to bind directly to DNA sequences (H. Wu & Zhang, 
2011) (Figure 1). In the case of TET2, the CXXC domain has become a 
separated protein named IDAX as the result of a chromosomal inversion 
event (Ko et al., 2013). 
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Figure 1. Domain architecture of mammalian Tet1, Tet2, and Tet3 proteins. 
Four conserved domains—including CXXC zinc finger domain (red), the 
cysteine-rich domain (green), the double-stranded β-helix (DSBH) fold (grey) 
of the 2-OG binding domain (orange) and Fe(II) binding domain (black)—are 
indicated. Tet2 does not contain a predicted CXXC domain. 
 
 
 
1.4 Regulators of TET activity and function 
 
Mounting evidence suggests that TET protein activity and recruitment are 
regulated at multiple levels. For instance, TET enzymatic activity can be 
stimulated by specific metabolites, cofactors, and post-translational 
modifications. Additionally, interaction with binding partners is likely to affect 
TET protein localization as well as protein stability. 
 
 
Vitamin C is one cofactor that positively regulates TET activity. Vitamin C has 
been shown to stimulate TET enzymatic activity in various cultured cells with 
increased levels of the cytosine oxidation products (Blaschke et al., 2013; 
Gustafson et al., 2015; Sasidharan Nair, Song, & Oh, 2016; Yue et al., 2016). 
Molecular study indicates that Vitamin C interacts directly with the catalytic 
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domain of TET proteins and provides a local reducing environment that 
increases recycling efficiency of the Fe (II) cofactor (Yin et al., 2013). 
 
 
The availability of key metabolites such as 2-OG is also important for TET 
activity. Mutations in genes coding isocitrate dehydrogenases 1 and 2 
(IDH1/2), succinate dehydrogenase (SDH), and fumarate hydratase (FH) 
have been reported in various types of cancers (Oermann, Wu, Guan, & 
Xiong, 2012). These mutations can result in the production of metabolites 
such as 2-hydroxyglutarate (2-HG) that compete with 2-OG. The 
accumulation of these metabolites has been shown to inhibit the enzymatic 
activity of TET proteins. 
 
 
TET proteins are also modified post-translationally. For example, TET 
proteins can bind to and be monoubiquitylated by the E3 ubiquitin ligase 
CRL4 (VprBP) on a highly conserved lysine residue at TET2 K1299 
(Nakagawa et al., 2015). This monoubiquitylation promotes TET protein 
binding to chromatin. Tet proteins have also been shown to undergo massive 
phosphorylation and O-GlcNAcylation at the N terminus and in the low- 
complexity insert region. These two modifications appear to act in a 
competitive manner (Bauer et al., 2015). These modifications have been 
suggested to allow for rapid modulation of TET protein localization and 
protein stability in response to different environmental stimuli. 
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1.5 Genome distribution of 5hmC, 5fC and 5caC 
 
While 5mC represents 4% to 5% of total cytosine, its oxidized form, 5hmC 
ranges from 0.1% to 0.5% of total cytosine and is highly variable across 
different tissues (Rasmussen & Helin, 2016). The products of further TET- 
mediated oxidation, 5fC, and 5fC, are observed at 10-fold and 100-fold lower 
than the abundance of 5hmC (Ito et al., 2011; Kriaucionis & Heintz, 2009; 
Szwagierczak et al., 2010). 
 
 
Mapping of the cytosine oxidation products has been performed in a number 
of tissues (Pastor et al., 2011; Szulwach et al., 2011; Williams et al., 2011; H. 
Wu et al., 2011; Xu et al., 2011). In ESCs, 5hmC enrichment was found at 
distal regulatory regions, gene bodies and intragenic regions with low CpG 
content, similarly, 5fC and 5caC were found mostly at distal regulatory 
regions but at a significantly lower amount compared with 5hmC (Pastor et al., 
2011; Williams et al., 2011). 
 
 
 
1.6 Potential roles for TET enzymes in mediating DNA demethylation 
 
Mechanistically, it has been suggested that conversion of 5mC to 5hmC by 
TET enzymes may provide a first step in long-sought-after DNA 
demethylation pathways. Both active and passive mechanisms have been 
proposed. 
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Passive demethylation refers to the failure to maintain DNA modification 
patterns during DNA replication process (Figure 2). During DNA replication, 
unmodified cytosine is incorporated into the newly synthesized strand, 
creating a hemi-modified CpG dinucleotide. A 5mC:C site is recognized by 
UHRF1, which helps to recruit DNMT1 to the hemi-5mC site. However, in 
vitro studies have shown that DNMT1 activity is reduced on a substrate DNA 
containing 5mC-oxidized products (Hashimoto et al., 2012). In this manner, 
5hmC-, 5fC-, and 5caC-modified CpG sites may promote demethylation 
through multiple rounds of DNA replication. 
 
 
In contrast, active DNA demethylation via 5mC oxidation has been suggested 
to involve base excision repair (BER) pathways (Figure 2). In particular, 
studies have implicated thymine DNA glycosylase (TDG) in this process. The 
TDG enzyme recognizes and excises mismatch in G:U and G:T base pairs, 
leaving abasic sites that can be subsequently detected and repaired by BER 
pathway (H. Wu & Zhang, 2014). In addition to these mismatches, TDG 
exhibits significant enzymatic activity toward 5fC and 5caC but not 5hmC in 
vitro (He et al., 2011; Spruijt et al., 2013). Based on these studies, an active 
DNA demethylation pathway has been proposed in which 5fC and 5caC 
generated by TET proteins from 5mC are excised by TDG, the abasic site is 
then replaced by an unmodified cytosine through BER pathway. The net 
outcome of this process is the reversal of 5mC to unmodified cytosine. 
Consistent with this model, studies have shown that deletion of Tdg in mouse 
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ESCs results in significant increase in 5fC and 5caC levels (He et al., 2011; 
Shen et al., 2013); conversely, overexpressing TDG in HEK293 cells leads to 
depleted 5fC and 5caC levels (Nabel et al., 2012). Taken together, the in vitro 
and in vivo data suggest TDG/BER-dependent pathway is at least one of the 
TET-mediated active DNA demethylation processes. 
 
 
Figure 2. Mechanisms of passive and active DNA demethylation. 
DNA methyltransferases (DNMTs) convert unmodified cytosine to 5-
methylcytosine (5mC). 5mC can be converted back to unmodified 
cytosine by TET-mediated oxidation to 5-hydroxymethylcytosine 
(5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), 
followed by excision of 5fC or 5caC mediated by thymine DNA 
glycosylase (TDG) coupled with base excision repair (BER) Figure 
based on Wu & Zhang, 2017.
9  
 
 
 
1.7 Additional functions for 5mC-oxidized products 
 
Given their stability and abundance, it is tempting to speculate that the 5mC- 
oxidized products have additional functions beyond their roles in promoting 
DNA demethylation. Indeed, recent findings using isotope labeling have 
revealed that 5hmC and 5fC are rather stable (Bachman et al., 2015, 2014). 
These results imply that 5hmC and 5fC can be uncoupled from active DNA 
demethylation pathways and may exhibit additional functions. In support of 
this hypothesis, analysis of TET activity has demonstrated that the rate of 
cytosine oxidation is significantly reduced for the 5hmC and 5fC substrates 
compared with 5mC substrate (Hu et al., 2013), this differential substrate 
preference can be attributed to subtle differences in the catalytic activity of the 
TET enzyme (Hu et al., 2015). It is, therefore, plausible that the intrinsic 
properties of TET enzymes restrain the oxidation process to form 5fC and 
5caC, leading to accumulated 5hmC in the genome that is independent of the 
active DNA demethylation pathway. 
 
 
Despite substantial efforts, only a few readers of 5hmC have been identified 
to date (Iurlaro et al., 2013; Song & Pfeifer, 2016). One confirmed 5hmC 
reader, UHRF2, exhibits specific binding activity to fully hydroxymethylated or 
hemi-hydroxymethylated DNA sequences over methylated DNA sequences 
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(Spruijt et al., 2013; Zhou et al., 2014). However, the biological significance of 
the binding of UHRF2 and 5hmC remains to be explored. Alternatively, some 
evidence suggests 5hmC might act to block binding of other proteins in some 
scenarios. For example, proteins that bind methylated DNA, such as MBD1, 
MBD2, and MBD4 exhibit lower binding affinity when oxidized 5mC products 
exist in the DNA substrates (Hashimoto et al., 2012; Jin et al., 2010). 
 
 
In contrast to 5hmC, studies have revealed a number of proteins that are able 
to bind to 5fC and 5caC (Spruijt et al., 2013; Iurlaro et al., 2013), suggesting 
these 5mC-oxidized products might encode additional epigenetic information. 
For example, RNA polymerase II (Pol II) has been shown to interact with both 
5fC and 5caC in vitro (Kellinger et al., 2012). Structural studies indicate that 
the interaction of Pol II and 5caC induces a positional shift of Pol II, which is 
unfavorable to the addition of nucleotides to the RNA strand (Wang et al., 
2015). The study suggests the interaction of Pol II and 5caC may regulate the 
elongation speed of genes with 5fC and 5caC within the gene bodies. Further 
in vivo analysis should help to elucidate the biological function of such 
interactions at the physiological level. 
 
 
 
1.8 Tissue specific expression of Tet genes in mammals 
 
In mammals, TET enzymes exhibit distinctive expression patterns in different 
tissues. For instance, mouse Tet1 and Tet2 are highly expressed in 
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embryonic stem cells (ESCs). However, upon differentiation, Tet1 becomes 
down-regulated while Tet3 is up-regulated. In oocytes, Tet1 and Tet2 are 
minimally expressed while Tet3 contributes to the early 5hmC synthesis in the 
zygote. Tet2 and Tet3 also exhibit high expression levels in a wide spectrum 
of adult tissues. Tet2 is the most highly expressed Tet family member in 
spleen and liver, while the expression level of Tet3 is the highest in tissues 
such as cerebellum and cortex. The expression of Tet1, in contrast, is 
relatively low in adult tissues (Szwagierczak et al., 2010). 
 
 
 
1.9 Mutation of Tet enzymes in mouse 
 
Individually, homozygous mutation of Tet1, Tet2 or Tet3 is compatible with 
mouse embryonic development, although Tet3 mutant mice die perinatally 
(Kohli and Zhang, 2013). Conditional deletion of Tet3 in oocytes results in 
delayed demethylation of the paternal genome and increased developmental 
failure, but viable pups can be recovered (Gu et al., 2011), the sub-lethality 
phenotype is likely caused by Tet3 haploinsufficiency (Inoue et al., 2015). 
 
 
In contrast to single mutants, combinatory loss of Tet1 and Tet2 in mice leads 
to a wide spectrum of defects, including exencephaly, growth retardation, and 
compromised imprinting. However, some mice survive and develop normally 
(Dawlaty et al., 2013). Embryos lacking Tet1 and Tet3 display abnormal 
embryonic phenotypes with increased transcriptome variability (Kang et al., 
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2015). Compared to single mutants, the complexity of the phenotypes in 
Tet1/2 and Tet1/3 double mutants strongly suggests that combinatory loss of 
Tet proteins is likely to result in epigenetic abnormalities that increase 
developmental stochasticity and compromise embryogenesis at multiple 
levels. To date, whole animal Tet2/3 double mutant mice have not been 
described. However, inactivation of all three Tet genes in mice leads to 
gastrulation phenotypes, including primitive streak patterning defects in 
association with impaired body plan formation. This phenotype has been 
attributed to hypermethylation of the Lefty gene in the absence of functional 
TET enzymes (Dai et al., 2016). Additionally, Tet1/2/3 triple-knockout ESCs 
show impaired differentiation and contribute poorly to chimeras (Dawlaty et 
al., 2014). All together, these studies suggest that TET family members have 
overlapping functions in promoting embryonic development. 
 
 
 
1.10 TET proteins in hematopoiesis and blood cancers 
 
TET proteins are particularly important to hematopoiesis and mutations in 
TET genes have been link to various types of blood cancers. In hematopoietic 
tissues, TET2 is the most abundant TET protein and genetic knockout of Tet2 
leads to increased hematopoietic stem cell (HSC) pool with skewed 
differentiation capability toward the myelomonocytic lineage in mice (Ko et al., 
2015, 2011; Z. Li et al., 2011; Moran-Crusio et al., 2011). Similarly, depletion 
of Tet1 results in an overall lymphoid bias and impaired B-cell lineage 
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differentiation (Cimmino et al., 2015). Mutation of Tet3 causes minor 
decreases in the absolute number of HSCs in the mouse bone marrow, while 
numbers of myeloid, erythroid and B lymphoid cells were unaffected (Ko et 
al., 2015). In addition, concomitant loss of Tet2 and Tet3 in mice at early B 
cell stage blocks the pro- to pre-B cell transition in the bone marrow (Lio et 
al., 2016). Overall, these data show that TET proteins are critical in controlling 
the differentiation and proliferation of HSCs and pro-B cells. 
 
 
Mutations in TET proteins have also been observed in a wide range of 
hematological disorders. TET1 was first identified as a fusion partner of MLL 
in acute myeloid leukemia and has essential oncogenic roles in some MLL- 
rearranged leukemias (Huang et al., 2013; Lorsbach et al., 2003). Alterations 
in TET2, on the other hand, are correlated with a wider range of 
hematological diseases. TET2 mutations have been reported in patients with 
myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia 
(CMML), acute myeloid leukemia (AML), myeloproliferative neoplasms 
(MPNs) (Bowman & Levine, 2017). Similar to the ESCs from Tet2-dificient 
mice, human cord blood cells depleted for TET2 and cells isolated from 
leukemia patients bearing TET2 mutations exhibit an increase in myeloid 
lineage differentiation at the expense of the erythroid lineage (Madzo et al., 
2014; Pronier et al., 2011). Besides, TET2 alterations are found in B-cell and 
T-cell lymphomas. Thus, TET2 mutations can be involved in very different 
types of hematological diseases, and recent studies support a role of TET2 
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mutations as one of the first genetic aberrations in the onset of hematological 
malignancies (Rasmussen & Helin, 2016). 
 
 
 
1.11 TET proteins in non-mammalian systems: flies, frogs and fish 
 
TET orthologs are also present in non-mammalian systems. Interestingly, the 
Drosophila genome encodes for a single TET ortholog despite having minimal 
5mC levels. The function of Drosophila Tet remains undetermined. It is 
possible that some non-catalytic functions of TET proteins are retained in 
Drosophila, for instance, recruiting transcriptional partners to target 
sequences. Alternatively, Drosophila Tet may act on tRNA, as Dnmt2, an 
RNA methyltransferase, is the only DNMT member identified in this organism 
(Goll et al., 2006). The ability of Drosophila Tet to rescue tet mutant 
phenotypes in other systems has not been explored. 
 
 
The Xenopus genome encodes two Tet ortholgs with closest homology to 
Tet2 and Tet3. Xenopus embryos injected with morpholinos targeting tet3 
exhibit early eye and neural phenotypes (Xu et al., 2012). The phenotype 
could be partly rescued by injecting mRNA encoding a catalytically inactive 
TET3, whereas injection with a TET3 CXXC domain mutant failed to rescue 
the phenotypes. Similarly, homozygous deletion of Tet3 in mice results in 
eye-related phenotypes including the Eyelid Open at Birth (EOB) phenotype 
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(Gu et al., 2011). This data suggest an evolutionally conserved function of 
Tet3 in eye development from vertebrate to mammals. 
 
 
The zebrafish genome encodes single well-conserved orthologs of Tet1, Tet2 
and Tet3 (Almeida et al., 2012). Previous studies have shown that tet2 mutant 
zebrafish exhibit similar MDS phenotypes to those observed in Tet2 mutant 
mice (Gjini et al., 2015), suggesting the conserved functions of TET proteins 
across different species. Intriguingly, while at least Tet3 is maternally deposited 
in mouse, few, if any, tet transcripts are detected in RNA-seq data from 2-cell 
stage zebrafish embryos and 5hmC is not detected in the  zebrafish embryo by 
immunofluorescence until the bud stage (Almeida et al., 2012; Gu et al., 2011). 
Zebrafish do not undergo the same TET dependent erasure and 
reestablishment of global 5mC patterns observed during mammalian 
preimplantation development, providing one potential explanation for this 
distinction (Jiang et al., 2013; Potok et al., 2013). The lack of maternal 
deposition and limited dependency on TET enzymes during the first 24 hours 
post fertilization make zebrafish a powerful system for examining TET 
requirements in later developmental processes, including those associated 
with tissue specific development and differentiation. A deeper interrogation of 
TET function in zebrafish is the subject of this thesis. 
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Section 2.  Zebrafish as a model for the study of hematopoiesis 
 
 
2.1 Overview of hematopoiesis 
 
Blood is among the tissues with the highest cell turnover rate. Billions of new 
blood cells are generated every day in our bodies to replenish the old ones 
through hematopoiesis. Hematopoiesis is defined as the development of all 
types of circulating blood cells derived from single HSC. While normal 
hematopoiesis needs to be assured to support the life-long requirement of 
blood cells, abnormal hematopoiesis is associated with a range of blood 
diseases, including cancer. Complicated genetic and signaling networks are 
integrated to govern HSC development and orchestrate the balance between 
self-renewal and differentiation (Orkin & Zon, 2008; Clements & Traver, 
2013). A full understanding of HSC development and how HSCs are 
regulated is a subject of particular interest because of the potential 
therapeutic applications. For example, de novo expansion of patient-derived 
HSCs could be used to reconstitute the entire blood system. Despite decades 
of intense research, generation of fully functional HSCs from pluripotent stem 
cells at large-scale remains challenging, partly due to the poor understanding 
of HSC development (Ciau-Uitz, Monteiro, Kirmizitas, & Patient, 2014; 
Sugimura et al., 2017; Wahlster & Daley, 2016). The internal development of 
HSCs in mammalian embryos complicates the study of their ontogeny and 
regulation. Given the surprising degrees of both functional and genetic 
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conservation between vertebrates, an alternative model to study the 
development of HSCs and translate human blood diseases is in demand. 
 
 
 
2.2 Advantages of the zebrafish model 
 
From studies over two decades, zebrafish has emerged as a powerful system 
to study developmental and to model human disease. Among its many 
advantages, the zebrafish model offers large brood size. Each pair of adult 
zebrafish can produce hundreds of embryos every week, which allows for 
large-scale screens similar to those performed in flies and worms (Patton & 
Zon, 2001). Zebrafish embryos also develop rapidly, with gastrulation 
completed within few hours after fertilization and most of the organs and 
structures formed within 24 hours post-fertilization (hpf) (Kimmel, Ballard, 
Kimmel, Ullmann, & Schilling, 1995). Externally fertilized embryos can be 
assessed as early as on the one-cell stage, enabling experimentations such 
as mRNA injection and morpholino knockdown (Bill, Petzold, Clark, 
Schimmenti, & Ekker, 2009). These transparent embryos are also ideal for 
the use of fluorescent imaging to study early embryonic processes, including 
heart development, vascular development, and hematopoiesis. 
 
 
 
2.3 Developmental hematopoiesis in zebrafish 
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Zebrafish provide an excellent platform to study the early development of the 
hematopoietic system. It is an ideal model for in vivo imaging, and it is useful 
for large-scale genetic screens. These advantages have led to the discovery 
of previously unknown players in hematopoiesis, improving our understanding 
of hematopoietic development. 
 
Most vertebrate experience two waves of hematopoiesis, primitive and 
definitive hematopoiesis. The transient primitive hematopoiesis gives rise to 
limited types of blood cells that provide oxygen and innate immunity to the 
rapidly growing tissues. The definitive wave, which follows the primitive wave, 
provides all types of blood cells derived from HSC to maintain the blood 
system throughout life (Figure 3). 
 
Primitive hematopoiesis: Primitive hematopoiesis in zebrafish initiates around 
 
10 hours post fertilization (hpf) and generates mainly macrophages and 
erythrocytes to support the growth of the early embryos (Jagannathan- 
Bogdan & Zon, 2013). Two intraembryonic regions have been shown to 
possess primitive hematopoietic activity: anterior lateral mesoderm (ALM), 
where most myeloid cells are produced, and posterior lateral mesoderm 
(PLM), where erythrocytes are produced. Precursor cells at ALM expressing 
scl, gata2, lmo2 and etsrp form a structure called rostral blood island (RBI) 
(Herbomel, Thisse, & Thisse, 1999; Paik & Zon, 2010). These cells then 
differentiate into macrophages to shape the developing tissues governed by 
transcription factors like PU.1. Meanwhile, precursor cells at PLM appear as 
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bilateral stripes and later migrate to central midline and form inner cell mass 
(ICM) (Detrich et al., 1995). Similar to the mammalian yolk sac island, 
zebrafish ICM region supports the production and maturation of primitive 
erythrocytes, which then enter circulation around 24 hpf when the heart starts 
beating (Figure 3). 
 
Definitive hematopoiesis: While primitive hematopoiesis is initiated by 
 
precursor cells that can only give rise to limited types of blood cells, the 
hallmark of definitive hematopoiesis is the emergence of hematopoietic stem 
cells (HSCs). These cells can give rise to the full range of erythroid, myeloid 
and lymphoid lineages to support the life-long requirements for blood cells. 
Following primitive hematopoiesis, there is a transient wave of definitive 
hematopoiesis derived from erythromyeloid progenitors (EMP) (Bertrand et 
al., 2007; McGrath et al., 2011). EMPs are found in posterior blood island 
(PBI) and have restricted differentiation capability to produce only erythroid 
and myeloid cells. It has been hypothesized that myeloid cells produced by 
EMPs can provide innate immune protection to the host and fill the gap before 
they arise from HSCs (Tober et al., 2007). 
 
 
At around 30 hpf, HSCs are first detected by the expression of transcription 
factors runx1 and c-myb in the ventral portion of the dorsal aorta. This region 
is commonly considered to be the equivalent to the mammalian aorta-gonad- 
mesonephrons (AGM) region (C. Burns, 2002; Kalev-Zylinska et al., 2002) 
(Figure 3). Using time-lapse confocal imaging to trace embryos expressing 
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both endothelial and HSC markers, two seminal studies demonstrated that 
HSCs directly emerge from transdifferentitaion of endothelial cells underlying 
dorsal aorta, a process termed endothelial-to-hematopoietic transition (EHT) 
(Bertrand et al., 2010; Kissa & Herbomel, 2010). During a typical EHT event, 
elongated endothelial cells start to express HSC markers. These cells 
gradually change their morphology and bend out into the mesenchyme 
beneath the dorsal aorta. Subsequently, cells bud off from the posterior 
cardinal vein and enter the circulation to become functional HSCs. Together 
with studies in mice (Boisset et al., 2010), these results indicate the 
endothelial origin of HSCs. The studies also argue for the existence of the 
hemogenic endothelium, a sub-population of endothelial cells underlying the 
blood vessels with the capacity to generate HSCs. At 48hpf, when most of the 
EHT events are completed, newly formed HSCs migrate and seed at 
posterior tail region called caudal hematopoietic tissue (CHT), where they 
undergo massive proliferation. By 3 days post-fertilzation (dpf), HSCs migrate 
to the thymus to initiate lymphogenesis. One day later, HSCs can be detected 
in the kidney marrow, the ultimate place for adult hematopoiesis. The kidney 
marrow can be considered analogous to the mammalian bone marrow (H. Jin, 
Xu, & Wen, 2007; Murayama et al., 2006) (Figure 3). 
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Figure 3. Primitive and definitive hematopoiesis in zebrafish 
 
Primitive erythroid progenitors are born in the intermediate cell mass (ICM). 
Circulation of primitive erythrocytes starts around 24hpf. The definitive wave 
begins around 30hpf during which time HSCs emerge from the ventral floor of 
the dorsal aorta within the aorta-gonad-mesonephros (AGM) region. The 
HSCs subsequently migrate to the caudal hematopoietic tissue (CHT) in the 
posterior region of the tail. By 3dpf, the thymus begins lymphopoiesis and 
HSC migrate to the kidney marrow around 4dpf. Figure based on 
Jagannathan-Bogdan & Zon, 2013). 
 
 
 
2.4 Conservation of regulators of hematopoietic stem cell development 
 
between zebrafish and other mammals 
 
 
 
Runx1: Runx1 is a transcription factor belongs to the RUNT family. RUNX1 is 
 
a key regulator of hematopoiesis and mutations are often observed in 
leukemia patients (Gaidzik et al., 2016; Gaidzik et al., 2011). Runx1 is 
expressed in functional HSCs in the adult mouse, as well as in cells with 
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spleen colony-forming unit (CFU) capability (North & de Bruijn, 2004). Runx1 
mutant mice fail to develop definitive blood cells, demonstrating a requirement 
for Runx1 in definitive hematopoiesis (Okuda, Van Deursen, Hiebert, 
Grosveld, & Downing, 1996). In zebrafish, Runx1 is first detected at 5-somite 
stage in the PLM and later expressed in both neural and hematopoietic 
tissues. At 30hpf, runx1 expression can be detected in HSCs that have just 
emerged from the AGM-like region. Although Runx1 appears to be 
dispensable for primitive hematopoiesis, it is required for definitive 
hematopoiesis, as morpholino knockdown of runx1 results in a loss of c-myb 
expressing cells (Kalev-Zylinska et al., 2002). Similarly, in Runx1-depleted 
embryos, the hemogenic endothelium fails to maintain its cell integrity and 
undergoes fragmentation at the onset of EHT (Kissa & Herbomel, 2010). 
Thus, Runx1 appears to be an important regulator controlling EHT process. 
Surprisingly, although most runx1 zebrafish mutants die from lack of definitive 
hematopoiesis, around 20% mutants survive and are capable of restoring 
multilineage hematopoiesis (Sood et al., 2010). One explanation for this 
phenotype is that other members of the Runt family may compensate the loss 
of Runx1 to reconstitute definitive hematopoiesis. 
 
 
c-myb: c-myb is a member of the MYB family of proto-oncogenes. c-myb is 
 
predominantly expressed in immature hematopoietic precursor cells and its 
expression decreases as these cells differentiate (Paik & Zon, 2010). 
Depletion of c-Myb in mice leads to lethality at gastrulation stage with a failure 
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in fetal lever erythoropoiesis, suggesting c-Myb is critical for definitive 
hematopoiesis (Mucenski et al., 1991). In zebrafish, c-myb expression is 
detected in runx1-expressing cells in the AGM-like region starting from 30 hpf. 
As a faithful HSC marker, c-myb expression can also be detected in the CHT 
at 2 dpf and later in thymus and the kidney (H. Jin et al., 2007; Murayama et 
al., 2006). Similar to Runx1, c-myb is dispensable for primitive hematopoiesis 
but is required for the definitive hematopoiesis, as c-myb mutant fish have 
complete loss of definitive blood cells (Soza-Ried, Hess, Netuschil, Schorpp, 
& Boehm, 2010). It has been demonstrated that c-myb facilitates the 
migration of HSCs from the ventral wall of dorsal aorta to CHT, which 
explains the failure of initiating definitive hematopoiesis in c-myb mutant 
embryos (Zhang, Jin, Li, Qin, & Wen, 2011). 
 
 
Scl: Scl encodes a basic helix-loop-helix (bHLH) transcription factor. In the 
 
mouse embryo, Scl is expressed in hemogenic sites including yolk sac blood 
islands, fetal liver, and the dorsal aorta (Paik & Zon, 2010). Additionally, Scl 
mutant mice are not able to initiate primitive hematopoiesis, suggesting its 
requirement in the primitive wave (Shivdasani, Mayer, & Orkin, 1995). During 
zebrafish development, scl is expressed around 2-somite stage in 
hemangioblast population together with gata2, lmo2 and etsrp. Scl is a key 
regulator of hemagioblast as morpholino knockdown of scl leads to severe 
defects in both vasculogenesis as well as primitive hematopoiesis (Dooley, 
Davidson, & Zon, 2005; Patterson, Gering, & Patient, 2005; Ren, Gomez, 
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Zhang, & Lin, 2010). Scl has also been shown to regulate definitive 
hematopoiesis. In zebrafish, two scl isoforms, sclα and sclβ, regulate HSC 
development at different stages (Qian et al., 2007; Zhen, Lan, Yan, Zhang, & 
Wen, 2013). Sclβ is expressed in the ventral wall of dorsal aorta and is 
required to specify the hemogenic endothelium, as Sclβ-depleted embryos 
have elevated numbers of apoptotic endothelial cells prior to the onset of 
EHT. In contrast, the sclα expression starts to accumulate after HSCs have 
budded off from the AGM-like region. Morpholino knockdown of sclα results in 
intact hemogenic endothelium specification but a loss of HSC population after 
EHT, demonstrating the specific requirements for different scl isoforms during 
HSC development. 
 
 
Gata2b: Gata2 is a well-known zinc finger transcription factor co-expressed 
 
with scl in hemangioblast at 2-somite stage. In mice, Gata2 is regulated by 
Notch signaling and is required within the endothelium for the expression of 
runx1 (Robert-Moreno, Espinosa, de la Pompa, & Bigas, 2005). Zebrafish 
genome encodes two gata2 paralogs, gata2a and gata2b. Morpholino 
knockdown of gata2a in zebrafish results in mild defects in primitive 
hematopoiesis (Galloway, Wingert, Thisse, Thisse, & Zon, 2005), 
nevertheless, gata2a mutant embryos display defects in aorta morphogenesis 
and circulation, indicating its primary role in regulating vasculogenesis (C. 
Zhu et al., 2011). A recent study reveals gata2b is specifically expressed in 
the hemogenic endothelium prior to the expression of runx1 (Butko et al., 
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2015). Additionally, gata2b-exprssing cells are capable of giving rise to adult 
hematopoietic cells, while embryos depleted of gata2b lose embryonic HSCs. 
Taken together, these data suggest that genome duplication in zebrafish 
endows subspecialized functions to Gata2b, which primarily controls HSC 
development by specifying the hemogenic endothelium. 
 
 
Notch Signaling: Notch signaling pathway controls cell fate and pattern 
 
formation. Studies in mice have demonstrated that defective Notch signaling 
pathway leads to decreased number of HSCs. Conversely, activation of Notch 
signaling pathway expands HSC population (Guruharsha, Kankel, & 
Artavanis-Tsakonas, 2012; Robert-Moreno et al., 2005, 2008). Zebrafish 
mindbomb mutant, which was first found in a forward genetic screen and 
studied for defective neural development, has defective Notch signaling 
activity due to the mutation in ubiquitin E3 gene required for Notch ligand 
processing (Itoh et al., 2003). Despite having intact primitive hematopoiesis 
and vasculogenesis, mindbomb mutants fail to specify HSCs (C. E. Burns, 
Traver, Mayhall, Shepard, & Zon, 2005). Transient expression of Notch 
intracellular domain rescues runx1+ c-myb+ cells. Subsequent studies have 
demonstrated that both cell autonomous and non-cell autonomous Notch 
signaling are required for the regulation of HSC development (Albert D Kim et 
al., 2014). Notch1a and Notch1b are expressed within the hemogenic 
endothelium and morpholino knockdown of either of these two Notch 
receptors reduces the number of HSCs. Importantly, the defect can be 
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rescued by activating Notch signaling at 20 hpf, the time when HSC 
precursors first experience Notch signaling. Notch3, on the other hand, is 
expressed in somite at 13 hpf. Morpholino knockdown of Notch3 in the 
embryos leads to decreased HSC population which can only be rescued by 
induction of Notch signaling at 14 hpf, indicating Notch3 is required non-cell 
autonomously. These results highlight the importance of Notch signaling 
during HSC development. 
 
 
BMP Signaling: Bone morphogenic proteins are a group of growth factors 
 
regulating tissue patterning and architecture. In mammals, chemical inhibition 
of BMP signaling leads to reduced HSC numbers contained within the AGM 
region (Durand et al., 2007). In addition, mouse AGM explants that contain 
nascent HSCs exhibit enhanced repopulation potential with the addition of 
Bmp4. These studies highlight the importance of BMP signaling in regulating 
HSC development. During zebrafish development, a reciprocal hedgehog- 
BMP gradient appears to be critical to polarize HSC formation from the 
ventral wall of the dorsal aorta (Wilkinson et al., 2009). Bmp4-inhibited 
embryos have intact arterial programs but fail to maintain the runx1 
expression and lack HSC population. It has been shown that BMP 
antagonists, such as noggin and gremlin, are expressed in tissues 
surrounding dorsal aorta prior to the appearance of HSC precursors. This 
Bmp4 repressive environment is at least partially regulated by FGF signaling 
(Pouget et al., 2014). Right before the onset of runx1 expression, expression 
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of these BMP antagonists reduces and bmp4 starts to express, switching 
Bmp4 repressive environment to BMP4 supportive environment to facilitate 
HSC emergence (Wilkinson et al., 2009). 
 
 
Wnt Signaling: Wnt signaling is crucial for stem cell development and function. 
 
Although most studies have confirmed a positive link between canonical Wnt 
signaling and HSC development (Reya et al., 2003; Willert et al., 2003), some 
studies suggest otherwise (Kirstetter, Anderson, Porse, Jacobsen, & Nerlov, 
2006; Scheller et al., 2006). It is likely that Wnt signaling regulates HSC 
development in a dosage-dependent manner ( Tiago C. Luis et al., 2011, 
2012). A chemical screen performed in zebrafish in search of molecules that 
alter the size of HSC population reveals PGE2 as a positive regulator of HSC 
development (Trista E North et al., 2007). Later studies demonstrate PGE2 
acts via cAMP/PKA to regulate Wnt-mediated HSC development (Goessling 
et al., 2009). Studies in zebrafish also reveal an important role of non- 
canonical Wnt signaling through Wnt16 ligand in regulating HSC development 
(Clements et al., 2011). Wnt16, together with FGF signaling and junction 
adhesion molecules, indirectly regulates HSC development by controlling the 
expression of two Notch ligands deltaC and deltaD in the somite (Clements et 
al., 2011; Kobayashi et al., 2014; Lee et al., 2014). Morpholino knockdown of 
wnt16 abolishes runx1+ and c-myb+ cells with intact vasculature and arterial 
specification. Transient expression of Notch signaling at 14 hpf rescues 
runx1+ cells at dorsal aorta. It has been shown that Notch receptor Notch3 
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orchestrates the non-canonical wnt16 signaling pathway and regulates HSC 
development non-cell autonomously (Albert D Kim et al., 2014). 
 
 
Inflammatory Signaling: Inflammatory signaling pathways are composed of 
 
secreted proteins and cytokines responsible for cell stress and infection. Their 
roles in regulating normal development are just beginning to emerge, and 
recent findings have unmasked the surprising involvements of inflammatory 
signaling during HSC development. Inflammatory signaling plays an 
evolutionarily conserved role in promoting definitive hematopoiesis from fish 
to mammals (He et al., 2015). In zebrafish, inflammatory signaling is highly 
enriched in hemogenic endothelium. IFNγ has been described to positively 
regulate HSC emergence in a cell autonomous manner downstream of Notch 
signaling (Sawamiphak, Kontarakis, & Stainier, 2014). Another inflammatory 
cytokine, TNFα, stimulates the expression of Notch ligand Jagged1a in 
endothelial cells and activates Notch signaling in the nearby hemogenic 
endothelium through Notch1 receptor (Espín-Palazón et al., 2014), a pathway 
that has been shown to be conserved between zebrafish and mammals (He 
et al., 2015; Li et al.,2014). Interestingly, these cytokines are secreted from 
primitive neutrophils and thus act in a non-cell autonomous manner to 
regulate HSC development (Espín-Palazón et al., 2014; He et al., 2015). 
 
 
2.5 Epigenetic regulation of hematopoiesis: early lessons from the zebrafish 
 
model 
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Studies in mice, cell culture and zebrafish have identified a number of 
transcription factors and signaling pathways that are important for HSC 
development (Jagannathan-Bogdan & Zon, 2013). However, much less is 
known about how epigenetic regulation contributes to the production and 
maintenance of HSCs in the developing embryo. The accessibility of early 
stages of HSC development and large brood sizes makes zebrafish well 
suited to genetic approaches aimed at identifying epigenetic regulators of 
HSC development. The application of forward and reverse genetic 
approaches in zebrafish is beginning to unravel the relevant epigenetic 
pathways. 
 
 
For example, a recent candidate screen for chromatin factors that regulate 
zebrafish hematopoiesis substantially expanded the number of epigenetic 
regulators implicated in HSC development. Screening of a panel of 425 
morpholinos that depleted proteins containing amino acid motifs associated 
with chromatin or nucleic acid binding revealed 31 candidates that caused 
strong alterations in runx1/c-myb expression levels (Huang et al., 2013). 
Among these candidates, 20 morpholinos impacted HSC development 
without negative effects on vascular or arterial development. Consistent with 
previous studies, this candidate screen implicated enzymes involved in 
histone modification including hdac1 and components of the PRC1 and 
SET1/trithorax complexes. In addition, several chromatin modifiers that had 
not been previously implicated in HSC development were uncovered, 
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including brd8a, jmjd1 and nap1l4a. An added advantage of the large-scale 
candidate approach is that it allows for identification of multi subunit 
complexes that include more than one gene implicated by the screen. This 
study demonstrates that candidate screen approach can be used to further 
evaluate epigenetic components in HSC development. 
 
A more extensive review of epigenetic regulation of hematopoiesis in 
zebrafish can be found in Appendix II. 
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CHAPTER TWO: EXPERIMENTAL RESULTS 
 
 
Section 1. Overlapping requirements for Tet2 and Tet3 in normal 
zebrafish development 
 
 
1.1 Systemic analysis of Tet gene requirements during zebrafish development 
 
The zebrafish genome encodes single well-conserved orthologs of TET1, 
TET2 and TET3 (Almeida et al., 2012). To systematically define requirements 
for these genes during development, we introduced mutations into the 
zebrafish TET ortholgs using TAL effector nucleases (TALENs) (Li et al., 
2011a; Sander et al., 2011). RNAs encoding TALENs that targeted tet1, tet2 
and tet3 were separately injected into one-cell stage embryos and individuals 
harboring germline transmissible mutations in each of the three genes were 
recovered. The recovered tet2mk17 allele deletes 4 base pairs in exon 8. This 
 
deletion results in a frame shift, causing early termination one amino acid 3’ of 
an essential iron-binding residue (Figure 4A and 4B). The tet1mk16 and  
tet3mk18 alleles harbor 4 and 14 base pair deletions, respectively, in the last 
coding exon. In addition to causing frame shift and premature termination, 
these deletions eliminate sequence encoding a C-terminal arginine residue 
that is required for 2-oxoglutarate binding (Hu et al., 2013) (Figure 4A and 
4B). Loss of specific residues involved in cofactor binding and catalysis is 
predicted to similarly compromise the dioxygenase activity of all three 
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enzymes. Zebrafish lines were then intercrossed to generate larvae that were 
homozygous mutant for all single, double and triple combinations. 
 
 
1.2 Tet2 and Tet3 are the major 5mC dioxigenases in the zebrafish embryo 
 
To assess 5hmC levels in the mutants, we performed dot blots using an 
antibody that is specific for the 5hmC modification. Modest (less than 3 fold) 
reductions in total 5hmC were observed in larvae that were homozygous 
mutant for tet1, tet2, or tet3 (Figure 4C). More considerable reductions in 
5hmC were observed in double mutants, with the tet2mk17/mk17, tet3mk18/mk18 
double mutant (tet2/3DM) combination producing the most dramatic decrease 
(>30-fold) (Figure 4C). 5hmC levels were further reduced in tet1/2/3 triple 
mutant (tet1/2/3TM) larvae; indicating that all three mutated genes encode 
proteins that are compromised for catalytic activity (Figure 4D). The enhanced 
loss of 5hmC in tet2/3DM larvae compared to other double mutant 
combinations argues that Tet2 and Tet3 are the predominant 5mC oxidases 
in the zebrafish embryo and that they function redundantly to promote the 
formation of 5hmC during development. 
 
 
1.3 Tet requirements during zebrafish development 
 
Zebrafish that were homozygous for mutations in tet1, tet2 or tet3 were viable 
to adulthood and fertile, as were tet1/2 and tet1/3 double homozygous 
mutants. In contrast, combined mutation of tet2 and tet3 was not compatible 
with survival beyond the larval period. The tet2/3DM larvae were 
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morphologically indistinguishable from wild-type controls during the first 24 
hours post fertilization (hpf), but subtle abnormalities in brain development 
emerged on the second day post fertilization (dpf). By 36 hpf, smaller eyes, 
abnormal brain morphology, altered pigmentation and a modest curvature of 
the trunk were apparent in 25% of larvae derived from intercrosses between 
tet2mk17/mk17, tet3mk18/+ adults (Figure 4E). Genotyping (n=20) confirmed that 
 
the morphologically abnormal embryos all carried homozygous mutations in 
both tet2 and tet3, demonstrating a combined requirement for the two genes 
in zebrafish development. Despite the additional reduction in 5hmC, 
tet1/2/3TM larvae were morphologically indistinguishable from tet2/3 double 
mutants at all stages examined (Fig 4F). 
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Figure 4. Mutation of zebrafish tet1, tet2, and tet3 
 
(A) Schematic illustrating early termination caused by TALEN mutations in zebrafish 
tet1, tet2 and tet3. Red octagons indicate the position of early termination signals. 
Yellow bars indicate conserved iron binding residues, the green bar indicates the 
arginine required for 2-oxogluterate binding. (B) Schematic depicting deleted bases in 
zebrafish tet1, tet2 and tet3. Corresponding amino acid sequences for the wild- type 
allele are included, with residues required for cofactor binding or catalysis indicated in 
red. (C) Dot blot for 5hmC on genomic DNA isolated from larvae at 5 dpf. Numbers 
indicate the mutated tet gene(s) in each sample. Sc indicates DNA isolated from 
Saccharomyces cerevisiae. Horizontal rows depict 3-fold serial dilutions  of DNA. (D) 
Dot blot for 5hmC on genomic DNA isolated from larvae at 5 dpf including 
DNA isolated from tet1/2/3
TM 
larvae. (E) Lateral views of a representative WT larva, a 
tet2/3
DM 
larva and a sibling larva derived from a tet2
mk17/mk17
, tet3
mk18/+ 
intercross at 36 
hpf. (F) Lateral views of a representative WT larva, a tet2/3
DM 
larva and tet1/2/3
TM
 
larva at 3 dpf. 
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Section 2. Overlapping requirements for Tet2 and Tet3 in HSC 
emergence 
 
 
2.1 Mutation of tet2 and tet3 causes loss of definitive blood 
 
Previous studies have suggested that TET regulation is of particular 
importance in hematopoietic lineage, and many studies have shown the 
correlation of TET mutations with various types of myeloid malignancies. 
While the importance of TET regulation in the adult hematopoietic system is 
clear, less is known about requirements for Tet genes during early stages of 
hematopoietic development. Given the combinatorial effects of tet2 and tet3 
mutation on overall development, and the known roles of TET proteins in later 
stages of hematopoiesis, we tested whether tet2 and tet3 had overlapping 
roles in the development of the definitive hematopoietic system. 
 
 
Consistent with a role for TETs in the early development of the hematopoietic 
system, our initial analysis revealed that tet2/3DM larvae lacked differentiated 
blood cells associated with the definitive wave. For example, while mature 
rag1-expressing T-cells were readily observed in the thymus of wild-type 
larvae at 5 dpf, rag1 positive cells were absent from the corresponding region 
of tet2/3DM larvae (Figure 5A-5B). Similarly, the Tg(lysC:GFP) transgenic line, 
which labels definitive granulocytes (Hall et al., 2007), produced a clear 
fluorescent signal in blood from wild-type larvae at 6 dpf, but fluorescent cells 
were not detected in tet2/3DM larvae at this stage (Figure 5C-5D). 
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Figure 5. tet2 and tet3 have overlapping functions in the HSC development 
 
(A and B) WISH for rag1 at 5 dpf. Arrow indicates thymic T-cells in wild-type larvae. 
(C and D) GFP labeled macrophages and neutrophils in 6 dpf larvae carrying the 
Tg(lysC:GFP) transgene. (E and F) WISH for the HSC marker runx1 in the DA at 36 
hpf. (G and H) WISH for the HSC marker c-myb in the DA at 36 hpf. (I) Number of 
sibling and tet2/3
DM 
embryos with wild type (+++), reduced (++), or nearly absent (+) 
runx1 labeling in the DA. Numbers are representative of three independent crosses. 
(J-M) WISH for runx1 in the DA at 32 hpf. (N) Graph indicating the percent of  tet2/3
DM 
larvae exhibiting high runx1 staining in the DA in uninjected controls or following 
injection with 100 pg of mRNA encoding TET2, TET2 H1382Y.D1384A 
(TET2 mutant) or TET3.  Numerical data is presented as the mean ± SEM. 
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2.2 Hematopoietic stem cell markers are not detected in tet2/3DM larvae 
 
 
The lack of differentiated blood cells derived from HSCs led us to next 
address whether HSC development was impaired in double mutants. During 
normal zebrafish development, HSCs emerge from the hemogenic 
endothelium in the ventral wall of the dorsal aorta (DA) starting from 30 hpf. 
In tet2/3DM larvae, we found the expression of the HSC-associated genes, 
runx1 and c-myb was reduced in the DA at these stages, whereas the runx1 
expression in tet2 and tet3 single homozygous mutant larvae appeared 
indistinguishable from wildtype (Figure 5E-5M). Moreover, in tet2/3DM larvae, 
c-myb positive hematopoietic stem and progenitor cells (HSPCs) could not be 
detected in the caudal hematopoietic tail (CHT) niche, a secondary, transient 
site for HSC amplification (Figure 6A-6F). All together, these observations 
suggest the HSC development is impaired in the double mutants. 
 
 
To confirm the specificity of the HSC phenotype observed in the double 
mutant larvae, we tested whether the phenotype could be rescued by 
reintroducing mRNA encoding different TET proteins. We found that injecting 
mRNA encoding either human TET2 or TET3 into one-cell stage embryos 
derived from tet2mk17/mk17, tet3mk18/+ intercrosses rescued the runx1 
expression, whereas injection of mRNA encoding a catalytically dead version 
of TET2 did not (Figure 5N). In addition to confirming the specificity of the 
HSC phenotype in tet2/3DM larvae, the rescue experiment directly implicates 
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the importance of 5mC dioxygenase activity of TET2 in regulating HSC 
development (Figure 5N). 
 
 
 
Figure 6. Reduced labeling of c-myb positive hematopoietic stem and 
progenitor cells in tet2/3DM larvae (A-B) WISH for c-myb at 57 hpf. (C-D) WISH for 
c-myb at 4 dpf. Arrow indicates the caudal hematopoietic tissue (CHT). (E-F) WISH 
for c-myb at 5 dpf. Arrow indicates the caudal hematopoietic tissue (CHT).  
 
 
 
 
2.3 Vascular development and blood flow are overtly normal in tet2/3DM larvae 
 
 
Normal vascular development, arterial specification, and blood flow-induced 
Nitric Oxide (NO) signaling are known prerequisites for HSC development 
(Adamo et al., 2009; Jagannathan-Bogdan and Zon, 2013; North et al., 2009). 
Therefore we next investigated whether defects in vascular development or 
blood flow might underlie HSC defects in tet2/3DM larvae. WISH for the 
vascular markers kdrl and cdh5, and the arterial marker efnb2a revealed 
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similar expression in wildtype and tet2/3DM larvae, demonstrating the 
presence of an overtly intact vasculature (Figure 7A-7F). Similarly, visual 
inspection of tet2/3DM larvae by bright field microscopy showed that blood flow 
was grossly normal during the first two days of development, and klf2a, an 
immediate early responder to blood flow, was expressed at similar levels in 
wild-type and tet2/3DM larvae (Figure 7G-7H). 
 
 
Figure 7. Vascular development and blood flow are overtly normal in tet2/3DM 
larvae. 
(A and B) WISH for the vascular marker kdrl at 31 hpf. (C and D) WISH for vascular 
marker cdh5 at 31 hpf. (E and F) WISH for the arterial marker efnb2a at 31 hpf. (G 
and H) WISH for the blood flow dependent marker klf2a at 36 hpf. 
 
 
In addition, while exposure to the NO agonist S-nitroso-N-acetyl-penicillamine 
(SNAP) was sufficient to rescue runx1 expression in silent heart (sih) 
morpholino injected embryos lacking blood circulation, SNAP exposure was 
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unable to rescue runx1 expression in tet2/3DM larvae (Figure 8A-8E). Taken 
together, these results suggest that the HSC defects observed in tet2/3DM 
larvae are not secondary to defects in vascular development or aberrant blood 
flow. 
 
 
Figure 8. SNAP does not rescue HSC development in tet2/3DM larvae. 
 
(A-B) WISH for runx1 in the DA of 36 hpf tnnt2a morpholino-injected embryos 
following exposure to DMSO or SNAP. (C-D) WISH for runx1 in the DA of 36 hpf 
tet2/3
DM 
embryos following exposure to DMSO or SNAP. (E) Number of tet2/3
DM
 
larvae exhibiting high (+++), low (++) or negligible (+) runx1 expression in the DA at 
36 hpf following exposure to DMSO or SNAP. 
 
 
 
 
2.4 tet2/3DM larvae exhibit impaired hematopoietic stem cell emergence 
 
 
Beginning around 32 hpf, nascent HSCs emerge from the ventral aortic 
endothelium of the zebrafish embryo through a process termed the 
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endothelial to hematopoietic transition (EHT) (Bertrand et al., 2010; Kissa and 
Herbomel, 2010). To test whether this process was impacted by mutations of 
tet2 and tet3, the tet2 and tet3 mutant alleles were introduced into a 
Tg(kdrl:Ras-mCherry)S896, Tg(kdrl:H2B-EGFP)mu122 transgenic background 
(Chi et al., 2008; Kochhan et al., 2013). In this background, membrane 
mCherry and nuclear GFP are expressed in the vascular endothelium and 
emergent HSCs, allowing EHT events to be identified based on stereotypical 
changes in cell morphology (Bertrand et al., 2010; Kissa and Herbomel, 
2010). Prior to the onset of EHT, tet2/3DM larvae and siblings from 
tet2mk17/mk17, tet3mk18/+ intercrosses exhibited similar fluorescent labeling with 
the two transgenes (Figure 9A-9B). A defined region of the DA was then 
monitored in tet2/3DM larvae and sibling controls (n=3 each) between 30 and 
46 hpf by time-lapse confocal microscopy. Analysis of image sets revealed a 
four-fold reduction in the number of EHT events detected in tet2/3DM larvae 
compared to siblings, indicating that EHT is compromised in the double 
mutants (average of 3 vs 13 EHT events, p=0.001; Figure 9C and 9E). 
 
In each time-lapse sequence from tet2/3DM larvae, we also observed between 
one and three cells within the DA undergoing nuclear fragmentation (Figure 
9D and 9F). In contrast, fragmentation was never detected in time-lapse 
sequences from siblings (Figure 9D). The nuclear fragmentation phenotype 
we observed in tet2/3DM larvae is reminiscent of that described for zebrafish 
embryos depleted for runx1 by morpholino injection, and suggests that a 
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fraction of cells undergoing EHT also die via apoptosis in the absence of 
 
tet2/3 (Kissa and Herbomel, 2010). 
 
 
 
 
 
 
 
Figure 9. tet2 and tet3 are required for the emergence of HSC through the 
endothelial to hematopoietic transition 
 
(A and B) Merged images depicting GFP and mCherry labeling of the vasculature in 
Tg(kdrl:Ras-mCherry), Tg(kdrl:H2B-EGFP) transgenic larvae at 30 hpf. (C) Number of 
EHT events detected between 30 and 46 hpf in tet2/3
DM 
larvae and siblings. Numerical 
data is presented as the mean ± SEM. (D) Number of fragmented nuclei observed in 
the DA of tet2/3
DM 
larvae and their siblings between 30 and 46 hpf. Numerical data is 
presented as the mean ± SEM. (E) Sequences documenting the stepwise emergence 
of an HSC from the DA of a sibling larva. For each time point, merged GFP and 
mCherry images are shown. The yellow arrow indicates the cell undergoing EHT. (F) 
Sequences documenting a cell undergoing nuclear fragmentation in the DA of a 
tet2/3
DM 
larva. For each time point, merged GFP and mCherry images are shown. The 
yellow arrow indicates the cell with nuclear fragmentation. 
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2.5 Tet2 and Tet3 regulated hematopoietic transcription factors in the 
 
hemogenic endothelium 
The reduction in EHT events in tet2/3DM larvae suggested a requirement for 
Tet2/3 in the function or specification of the hemogenic endothelium, which 
gives rise to nascent HSCs. The hematopoietic transcription factors runx1 
and scl are both expressed in the hemogenic endothelium prior to the 
initiation of EHT and are required for this process (Kissa and Herbomel, 2010; 
Zhen et al., 2013). By WISH, we found that expression of both runx1 and scl 
was reduced in the DA of tet2/3DM larvae prior to HSC emergence, suggesting 
that Tet2 and Tet3 are required to promote the hemogenic potential of the 
vascular endothelium (Figure 10A-10D). Expression of scl and runx1 is 
controlled in part by the transcription factor Gata2 in mouse, and the zebrafish 
genome encodes for two Gata2 paralogs that have undergone 
subfunctionalization (Butko et al., 2015; Gao et al., 2013; Gottgens et al., 
2002; Pimanda et al., 2007). Zebrafish gata2a is broadly expressed 
throughout the hematopoietic system, and is important for vascular 
morphogenesis (Zhu et al., 2011). In contrast, zebrafish gata2b is specifically 
detected in the hemogenic endothelium and is required for runx1 expression 
within this tissue (Butko et al., 2015). Consistent with the HSC specific 
phenotypes observed in tet2/3DM larvae, we found that tet2/3 mutation 
compromised expression of gata2b, while gata2a expression was unaffected 
at similar stages (Figure 10E-10H). Collectively, these observations identify 
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Tet2/3 as essential regulators of the gata2b/scl/runx1 transcriptional network 
in the hemogenic endothelium. 
 
 
To clarify whether the disruption of gata2b/scl/runx1 transcriptional program 
could account for the HSC defects observed in tet2/3DM larvae, we next tested 
whether reintroducing mRNA encoding scl or gata2b into tet2/3DM embryos 
could rescue HSC production. In vitro transcribed mRNA encoding scl or 
gata2b was injected into one cell-stage embryos derived from tet2mk17/mk17, 
tet3mk18/+ intercrosses and runx1 expression was subsequently examined in 
the DA of tet2/3 double mutants by WISH at 36 hpf. Injection of either mRNA 
was sufficient to rescue wild-type levels of runx1 expression in the DA of 
tet2/3DM larvae, identifying the gata2b/scl/runx1 network as the primary 
hematopoietic program regulated by Tet2/3 during HSC emergence (scl: 
p=0.0004, gata2b: p=0.0008, Figure 10L-10M). 
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Figure 10. Tet2/3 regulate expression of the gata2b/scl/runx1 transcriptional 
network in the hemogenic endothelium 
 
(A-B) WISH for scl at 31 hpf. (C-D) WISH for runx1 at 24 hpf. (E-F) WISH for gata2b 
at 24 hpf. (G-H) WISH for gata2a at 24 hpf. (I-J) WISH for runx1 in the DA of 
uninjected and sclβ mRNA-injected tet2/3DM embryos at 36 hpf. (K-L) WISH for runx1 
in the DA of uninjected and gata2b mRNA-injected sibling embryos at 36 hpf. (M) 
Percent of tet2/3
DM 
embryos with high runx1 expression following mock injection, 
injection with mRNA encoding Sclβ (50pg) or Gata2b (200pg). Numerical data is 
presented as the mean ± SEM. 
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2.6 Tet2 and 3 are required for Notch signaling in the hemogenic endothelium 
 
Analysis of genomic DNA from sorted vascular endothelial cells revealed that 
the promoters of gata2b, runx1 and scl were similarly unmethylated in 
wildtype and tet2/3DM larvae, suggesting that Tet2/3 do not directly regulate 
expression of these genes via promoter demethylation (Figure 11). This 
observation raised the possibility that Tet2/3 act upstream of gata2b in 
regulating HSC emergence. Notch signaling is required for the expression of 
gata2b in the zebrafish hemogenic endothelium and Gata2 is a direct target of 
Notch signaling in the mouse dorsal aorta, making this pathway a strong 
candidate for Tet2/3 regulation during HSC emergence (Butko et al., 2015; 
Robert-Moreno et al., 2005). 
 
Figure 11. Promoter methylation at runx1, scl and gata2b is unaffected in 
tet2/3DM larvae 
 
Bisulfite sequencing of the region upstream of the transcriptional start site for runx1, 
scl and gata2b. DNA was isolated from FACs sorted kdrl:mCherry positive cells at 28 
hpf. Open circles indicate unmethylated CpGs, filled circles indicate CpGs in which  
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the cytosine residue carries either the methyl or hydroxymethyl modification. Each 
horizontal row indicates an individual bisulfite clone. 
 
 
 
Notch signaling allows for communication between cells in close proximity. 
The ligand secreted by the donor cell bind to the receptor of the recipient cell, 
inducing a series of proteolytic cleavages of the Notch receptor that release 
the Notch intracellular domain (NICD). Once released, NICD enters the 
nucleus and, together with transcriptional partners such as RBPjK and co- 
activator Mastermind, stimulates the transcription of Notch target genes 
(Bray, 2016). The communication between cells through Notch signaling is 
required for many tissue specification, lineage commitment, and cell 
maintenance events throughout development. Among the many 
developmental processes, Notch signaling is especially important to 
hematopoiesis. 
 
To test whether mutation of tet2/3 disrupted Notch signaling in the hemogenic 
endothelium, we introduced the tet2 and tet3 mutant alleles into a Notch 
reporter line, Tp1:GFP, which expresses GFP under the control of tandem 
Notch responsive elements (Parsons et al., 2009). At the whole embryo level, 
wildtype and tet2/3DM larvae exhibited similar patterns of GFP expression 
from the Tp1:GFP transgene, suggesting that Notch signaling was not 
globally compromised by mutation of tet2/3 (Figure 12A-12D). 
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Figure 12. Tp1:GFP expression reveals similar overall patterns of Notch 
signaling in sibling and tet2/3DM larvae 
(A-B) Bright-field images of a representative sibling and tet2/3DM larvae at 26 
hpf. (C-D) GFP expression in Tp1:GFP transgenic larvae at 26hpf. 
 
At higher resolution, morphologically wild-type embryos carrying the TP1:GFP 
transgene exhibited the expected strong expression of Tp1:GFP along both 
the dorsal and ventral walls of the DA (Figure 13A). In tet2/3DM larvae, 
Tp1:GFP expression on the dorsal side of the DA appeared similar to wild 
type, however, expression along the ventral wall appeared weaker and 
discontinuous (n=10/11, Figure 13B). Quantification of mean GFP fluorescent 
intensity in each region revealed a 3-fold reduction in the ratio of GFP 
fluorescence in the ventral DA compared to the dorsal DA in tet2/3 double 
mutants (p=0.0002, Figure 13C). This specific reduction in GFP in the ventral 
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DA reveals a requirement for Tet2/3 in regulating Notch signaling in the 
hemogenic endothelium and provides a mechanistic explanation for the down 
regulation of gata2b observed in tet2/3DM larvae. 
 
 
Figure 13. Tet2/3 are required for Notch signaling in the hemogenic 
endothelium 
 
(A-B) Confocal images of Tp1:GFP expression in the dorsal aorta of sibling and 
tet2/3
DM 
larvae at 28 hpf. DDA indicates the dorsal wall of the dorsal aorta. VDA 
indicates the ventral wall of the dorsal aorta. (C) Ratio of GFP fluorescence intensity 
in the VDA/DAA in sibling and tet2/3
DM 
larvae (n=11 per genotype). Numerical data is 
presented as the mean ± SEM. 
 
 
 
 
To examine whether Notch signaling is sufficient to rescue impaired HSC 
development in tet2/3 double mutants, we overexpressed NICD within the 
vascular endothelium. The kdrl:miniGAL4 transgenic line drives the 
expression of transcriptional activator GAL4 in kdrl+ cells, while the 
UAS:NICD-myc transgenic line allows for the expression of NICD when 
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transcriptional activators bind to the regulatory elements UAS. Thus, 
kdrl:miniGAL4 and UAS:NICD-myc double transgenic lines enable restricted 
NICD expression to the kdrl+ cells enriched in the vascular endothelium (Kim 
et al., 2014). This pattern was confirmed by immunostaining against myc tag, 
which revealed the vascular endothelial cells only in individuals with both 
transgenes exhibited elevated NICD expression (Figure 14A-14B). 
 
 
 
Figure 14. Kdrl:miniGAL4 and UAS:NICD-myc double transgenic lines enable 
restricted NICD expression in the vascular endothelial cells 
 
(A). Bright-field image and myc expression of a representative larva (one out of six) 
carrying both kdrl:miniGAL4 and UAS:NICD-myc at 30 hpf. Yellow arrows indicate 
the restricted expression of myc in the vascular endothelial cells. (B) Genotype of 
twelve larvae tested (number 1 to 6: larvae carrying both kdrl:miniGAL4 and 
UAS:NICD-myc). 
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We next introduced tet2 and tet3 mutations into kdrl:miniGAL4 and 
UAS:NICD-myc transgenic lines to obtain kdrl:miniGAL4;tet2mk17/+;tet3mk18/+ 
and UAS:NICD-myc;tet2mk17/+;tet3mk18/+, respectively. Runx1 and c-myb WISH 
were performed on the embryos derived from the intercross, and the 
genotype of the individual embryo was subsequently confirmed by PCR 
genotyping. While mutants carrying none or only one of the transgenes (5/38) 
lacked HSCs as before (5/38), runx1 expression was rescued in the DA of 
double mutant larvae carrying both transgenes at 32 hpf (6/6) (Figure 15A- 
15C). Similar to the runx1 expression, the c-myb expression was also 
observed in double mutant larvae carrying both transgenes at 32 hpf (Figure 
15D-15E). However, the c-myb expression in tet2/3DM larvae was lost by 3 
dpf, suggesting Notch signaling is not sufficient to support the HSPCs after 
they are specified in the tet2/3DM larvae (Figure 15F-15G). 
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Figure 15. Overexpressing Notch signaling rescues the runx1+ and c-myb+ 
cells in tet2/3DM larvae at 32hpf 
 
(A-C) WISH for the HSC marker runx1 at 32 hpf. (D-E) WISH for the HSC marker c- 
myb at 32 hpf. (F-G) WISH for the HSC marker runx1 at 3dpf. 
 
 
 
 
Taken together, these results uncover a requirement for Tet2/3 in the early 
function of the hemogenic endothelium and identify Notch signaling and the 
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downstream expression of the gata2b/scl/runx1 transcriptional network as key 
targets of Tet2/3 regulation during HSC emergence. 
 
 
 
Section 3: Altered inflammatory signaling is associated with impaired 
primitive hematopoiesis in tet2/3DM larvae 
 
3.1 Inflammatory signaling genes are down-regulated in the vascular 
endothelial cells of tet2/3DM larvae 
To clarify mechanisms that might act upstream of Notch signaling that 
contribute to the HSC phenotype in tet2/3DM larvae, we performed massively 
parallel RNA sequencing on isolated vascular endothelial cells prior to the 
onset of EHT. The kdrl:mCherry transgenic line enables the isolation of 
mCherry+ cells enriched for vascular endothelial population by fluorescent 
activated cell sorting. We set the stage at 26 hpf for cell sorting as it was the 
earliest time we could confidently distinguish the tet2/3DM from siblings. The 
hemogenic endothelium had also been specified at 26 hpf (Zhen et al., 2013). 
The isolated mCherry+ cells from mutants and siblings were subsequently 
used for RNA sequencing (40 millions reads, 100bp paired ends). Using a 
threshold of FDR < 0.05 with Log2FC > 1 or Log2FC < -1, the RNA 
sequencing results showed 101 genes were up-regulated and 214 genes 
were down-regulated in the mCherry+ cells from tet2/3DM larvae compared 
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with siblings (Figure 16). GO analysis revealed that a large number of these 
genes (25%) were involved in inflammatory signaling (Figure 17). 
 
 
Figure 16. Heatmap of 315 genes that are differentially expressed in the 
mutant compared to the siblings with fold change greater than 1 and adjusted 
p-value less than 0.05. 
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Figure 17. Heatmap of the most down-regulated inflammatory genes in the 
mutant compared to the siblings using supervised analysis. Figure lend on the 
right indicates the corresponding gene names. 
 
 
 
Enrichment for inflammatory genes was of interest as recent studies have 
identified connections between inflammatory signaling and development of   the 
hemogenic endothelium. Inflammatory signaling molecules are highly enriched 
in hemogenic endothelium both in zebrafish and mammals (He et al., 2015). In 
particular, IFNγ and its receptor act cell-autonomously to control  EHT transition 
downstream of Notch signaling (Sawamiphak et al., 2014). Inflammatory 
cytokines such as TNFα have also been shown to stimulate Notch activity in the 
hemogenic endothelium through the Notch receptor (Espín-Palazón et al., 2014, 
He et al., 2015; Li et al.,  2014), contributing to  the establishment of the 
transcriptional network for EHT. Supported by these 
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studies,  our  RNA  sequencing  data  revealed  the  HSC  phenotypes  in  the 
 
tet2/3DM larvae could be attributed to the loss of inflammatory signaling. 
 
 
3.2 Abnormal development of primitive myeloid cells in tet2/3DM larvae 
 
 
Once source of inflammatory cytokines are primitive neutrophils. These 
signals have been shown to act in a non-cell autonomous manner to regulate 
the hemogenic endothelium (Espín-Palazón et al., 2014; He et al., 2015). Our 
initial analysis noted that early markers of primitive hematopoiesis were 
normal in tet2/3DM larvae as assessed by expression of gata1, scl and pu.1 at 
25 hpf by WISH (Figure 18A-18I). 
 
 
 
Figure 18. Primitive markers are similarly expressed in the wildtype, 
tet2mk17/mk17 and tet2/3DM larvae. 
(A-I) Representative lateral views of wild-type larvae compared to tet2/3
DM 
and 
tet2
mk17/mk17 
sibling larvae derived from tet2
mk17/mk17
, tet3
mk18/+ 
intercrosses. (A-C) 
WISH for the primitive erythroid marker gata1 at 25 hpf. (D-F) WISH for the primitive 
erythroid marker scl at 25 hpf. (G-I) WISH for the primitive myeloid marker pu.1 at 25 
hpf 
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However, our RNA sequencing data indicated that other genes associated with 
myeloid differentiation were deregulated in tet2/3DM larvae. In particular, we 
noted that csf3a and csf3b, encoding GCSF proteins, were significantly down 
regulated (Figure 17). This family of glycoproteins are known to stimulate the 
proliferation, differentiation, and function of myeloid precursors and mature 
myeloid cells, suggesting that their might be defects in myeloid cell 
development in tet2/3DM larvae. 
 
Intriguingly, csf3a/3b was previously shown to expand the HSC population in 
zebrafish, while morpholino knock-down caused significant decreases in HSCs 
(Stachura et al., 2013). To evaluate whether down-regulation of csf3a/3b 
contributes to the HSC phenotype in the tet2/3DM larvae, we injected embryos 
from tet2
mk17/mk17
, tet3
mk18/+ 
intercrosses with mRNAs encoding Csf3a or Csf3b. We 
found that overexpressing either gene rescued the runx1 expression in the 
tet2/3DM (Figure 19). The data suggest that overexpression of csf3a/3b is 
sufficient to rescue the HSC phenotype observed in the tet2/3DM. 
58 
 
 
 
 
Figure 19. Quantification of WISH for runx1 in siblings and tet2/3DM injected 
with wither csf3a or csf3b RNAs 
 
 
 
Given the involvement of csf3a/b in regulating myeloid cell maturation and the 
known link between myeloid mediated inflammatory signals and HSC 
development, we set out to examine whether primitive myeloid populations 
are affected in the tet2/3DM larvae. Although pu.1, marker of undifferentiated 
primitive myeloid cells appeared similar in wild type and mutants, we noted 
that, mfap4, which specifically label primitive macrophages, was down 
regulated (Figure 20D-20F). By performing WISH for primitive neutrophil 
marker mpx, we found primitive neutrophil population remained largely 
unchanged in the tet2/3DM (Figure 20A-20C). 
 
Taken together, our RNA sequencing analysis and genetic studies are 
consistent with a model in which inflammatory signaling acts upstream of 
Notch signaling to control the HSC development. We hypothesize that 
reduced csf3a/3b expression in the tet2/3DM negatively affects the primitive 
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myeloid cell population causing disruption of inflammatory signaling required 
for proper development of the hemogenic endothelium. To confirm the 
epistasis of inflammatory signaling and Notch signaling, future experiments 
should examine whether overexpressing csf3a/3b leads to restored Notch 
activity in the hemogenic endothelium of the tet2/3DM. To study whether 
impaired primitive myeloid cells directly contribute to the HSC phenotypes in 
 
tet2/3DM larvae, we could theoretically transplant wild-type primitive 
macrophages to the tet2/3DM and evaluate the expression of HSC markers. 
 
Figure 20. tet2 and tet3 are required for the development of primitive 
macrophages 
(A-B) WISH for the primitive mutrophils marker mpx at 26hpf. The red arrow 
indicates the mpx+ cell in the AGM region. (C) Quantification of the number of mpx+ 
cells in the AGM region. (D-E) WISH for the primitive macrophages marker mfa4 at 
26hpf. The yellow arrow indicates the representative mfap4+ cell on top of the yolk 
sac. (F) Quantification of the number of mfap4+ cells on top of the yolk sac.
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Section 4. Enhanced Tet1 activity can compensate for loss of Tet2 and 
Tet3 during HSC emergence 
 
 
4.1 Overexpressing mRNA encoding Tet1 rescues HSC development in 
tet2/3DM larvae 
All TET family members share highly conserved catalytic domains at the C- 
terminus, allowing them to execute successive oxidation of 5mC to various 
oxidized derivatives. However, the extent to which TET family members can 
compensate for each other remains unclear. Our genetic analysis has 
demonstrated that there are overlapping requirements for Tet2 and Tet3 
during the HSC development in zebrafish, but Tet1 is dispensable for this 
process. However, we find that tet1 is expressed at significantly lower levels 
than tet2 and tet3 in whole embryos and in the kdrl positive vascular 
endothelial cells at the relevant stages (Figure 21A-21B). These observations 
suggest that it may be the relative abundance of particular TET enzymes 
rather than an inherent specificity that dictates their requirements.  To test this 
hypothesis, we asked whether overexpression of mRNA encoding Tet1 could 
rescue HSC phenotypes in tet2/3DM larvae. 
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Figure 21. tet expression in whole embryos and kdrl+ cells at 26hpf 
 
(A) qRT-PCR analysis of tet expression in whole embryos collected at 26hpf. (B) qRT-
PCR analysis of tet expression in kdrl+ cells sorted at 26hpf. Numerical data is 
presented as the mean ± SEM from three independent groups. 
 
 
 
 
To this end, we injected mouse Tet1 RNA into the zebrafish embryos derived 
from tet2mk17/mk17, tet3mk18/+ intercrosses. Overexpression of Tet1 RNA in wild- 
type embryos did not cause developmental abnormalities with the exception 
of a tail blister, which occurred in 26% of injected embryos (Figure 22A-22B, 
22D)(Figure 22C, 22E). However, over expression was able to rescue runx1+ 
HSCs in tet2/3DM larvae (Figure 22G-22H). Consistent with this rescue, we 
noted that overexpressing Tet1 RNA partially increased 5hmC levels in 
tet2/3DM larvae (Figure 22F). These data suggest that the overexpression of 
Tet1 can compensate the loss of Tet2 and Tet3 during the development of 
HSCs. Our results provide evidence that members of Tet family behave 
similarly and can act interchangeably when expressed at sufficient levels. 
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Figure 22. Overexpressing Tet1 RNA can compensate the loss of Tet2 and 
Tet3 
(A-E) Pictures of representative larva of control groups and Tet1 RNA injected 
groups. Numbers in the lower left hand corner indicate the fraction of embryos with 
morphology similar to the representative image. (F) Methylene blue staining and dot 
blot for 5hmC on genomic DNA isolated from larvae at 32hpf. (G) WISH for the HSC 
marker runx1 at 32hpf. (H) Quantification of the percent of tet2/3
DM 
larvae exhibiting 
high runx1 staining in uninjected and Tet1 RNA injected group. Numerical data is 
presented as the mean ± SEM. 
 
 
 
4.2 Stimulation of endogenous Tet1 activity can rescue the HSC phenotypes 
in tet2/3DM larvae 
TET proteins can be either regulated at transcriptional level by modulating Tet 
expression or at the level of activity by various protein modifications or the 
presence of co-factors. One such co-factors, vitamin C, is a potent antioxidant 
and has been shown to enhance TET activity in ES cells with an increase in 
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the global 5hmC content. Compared with other reducing agents, Vitamin C 
can uniquely interact with the C-terminal catalytic domain of TET enzymes, 
promoting the recycling of iron during the oxidation processes. The capacity 
of vitamin C to robustly induce TET activity has also been shown across a 
wide spectrum of cells, including mouse embryonic fibroblasts, T regulatory 
cells, and melanoma cells. However, this capacity has not yet been tested in 
an in vivo model. Our zebrafish model provides a promising platform to test 
the in vivo potency of vitamin C to stimulate TET enzymatic activity. 
 
 
We set out to examine whether vitamin C treatment could stimulate Tet1 
activity and whether it was sufficient to rescue HSC development in 
tet2/3DMlarvae. We found that vitamin C treatment did not impact overall 
development of zebrafish larvae at tested concentrations (1mM), nor did it 
affect the endogenous tet expression (Figure 23A-E). However, 
supplementing vitamin C resulted in a dose-dependent increase in the 5hmC 
levels in both siblings and tet2/3DM larvae (Figure 24F). In addition, we found 
that runx1+ cells were rescued in the tet2/3DM when treated with vitamin C 
(Figure 24A-24E). To confirm that the rescue of runx1 expression was 
mediated through the stimulation of Tet1, we tested whether rescue was still 
possible in tet1/2/3TM larvae. Using the same dose of vitamin C, runx1+ cells 
were not detected in triple mutants, suggesting that rescue was mediated 
through Tet1 stimulation (Figure 24G-24H). 
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Figure 23. Vitamin C (AA) treatment minimally affects the morphology and the 
expression of tet1 in siblings and tet2/3DM 
(A-D) Representative pictures of siblings and tet2/3
DM 
either untreated or treated with 
1mM Vitamin C. (E) qRT-PCR analysis of tet1 expression in siblings and tet2/3
DM 
either untreated or treated with 1mM Vitamin C. Numerical data is presented as the 
mean ± SEM from three independent experiments. 
 
 
Taken together, these results confirm the in vivo potency of vitamin C to 
stimulate TET enzymatic activity. More importantly, our study shows the HSC 
defects in the tet2/3DM can be rescued by stimulating endogenous Tet1 
activity via vitamin C treatment, suggesting there is the potential to use 
vitamin C to treat TET-related diseases. Our system also sets the stage for 
screens for additional factors that rescue the HSC defects, which may 
potentially regulate Tet1 activity or expression. 
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Figure 24. Vitamin C treatment rescues the HSC phenotype in tet2/3DM larvae 
(A-D). WISH for the HSC marker runx1 at 30hpf in siblings and tet2/3DM either 
untreated or treated with 1mM Vitamin C. (E) Quantification of the percent of 
tet2/3
DM 
larvae exhibiting high runx1 staining in siblings and tet2/3DM either 
untreated or treated with 1mM Vitamin C. Numerical data is presented as the 
mean ± SEM. Pictures in panel A-E were prepared by Lianna Schwartz-Orbach. 
(F) Dot blot for 5hmC  on  genomic  DNA  isolated  from  larvae  at 32hpf  treated  with 
1mM or 3mM Vitamin C. (G, H) WISH for the HSC marker runx1 at 30hpf in siblings 
and tet1/2/3TM either untreated or treated with 1mM Vitamin C. Numbers in the 
lower right hand corner indicate the fraction of embryos exhibiting WISH labeling 
similar to the representative image. 
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Section 5. Applications of using the tet2/3DM as a platform to study 
novel regulators of TET proteins 
 
5.1 Identifying suppressors of HSC loss in tet2/3DM larvae 
 
 
In section 4, we demonstrated that either overexpressing Tet1 mRNA or 
stimulating endogenous Tet1 activity rescues HSC defects in tet2/3DM larvae. 
Based on these observations, we reasoned that tet2/3DM larvae could be used 
as a platform to identify additional modulators of Tet1 activity. As a first 
approach, we performed a pilot small molecule suppressor screen designed 
to identify small molecules that stimulated Tet1 expression or activity. To this 
end we used the Selleck Epigenetics Compound library, which contains 181 
small molecule modulators with biological activity in epigenetic regulation. 
Groups of an average 20 embryos derived from intercrosses between 
tet2mk17/mk17, tet3mk18/+ adults were treated with compounds from this library at 
a concentration of 15mM beginning at 8hpf. Treated embryos and untreated 
controls were then collected at 30hpf and assayed for runx1 by WISH. 
Compounds that resulted in higher expression level of runx1 in double 
mutants compared with untreated double mutant controls were identified as 
candidates for additional analysis. 
 
 
Using this approach, we identified three drugs SGI-1776, M344, and LAQ824 
that were able to reproducibly rescue the runx1 expression in the tet2/3DM 
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larvae. These compounds included the PIM kinase inhibitor SGI-1776 and the 
histone deacetylase (HDAC) inhibitors M344 and LAQ824. 
PIM kinases are a small family of serine/threonine kinases regulating several 
signaling pathways that are fundamental to cancer development and 
progression (Swords et al., 2011). HDACs are a class of enzymes that 
remove acetyl groups from a histone, an activity associated with 
transcriptional repression (Haberland, Montgomery, & Olson, 2009). Based 
on their mechanism of action, we tested the likely hypothesis that HDAC 
inhibition caused elevated levels of tet1 transcription in tet2/3DM larvae. 
However, we did not detect statistically significant changes in tet1 expression 
in treated larvae (Figure 25), suggesting that either tet1 upregualtion was only 
in a subset of cells diluted out in our whole embryo analysis or that other 
mechanism mediate the suppression of HSC loss in tet2/3DM larvae. For 
example, HADC inhibition may directly derepress genes involved in the HSC 
developmental program. 
 
 
Although additional follow up will be required, the results of this preliminary 
chemical suppressor screen, suggest that this approach may be a promising 
application of the tet2/3DM larvae. 
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Figure 25. LAQ824 treatment does no increase tet1 expression. Numerical 
data is presented as the mean ± SEM from five independent experiments. 
 
 
 
 
5.2 Clarifying the importance of TET-OGT interactions using tet2/3DM larvae 
The tet2/3DM larvae also offer an exciting platform for in vivo structure/function 
analysis of TET mutant proteins. Validating this approach, in collaboration 
with the Panning lab (UCSC) we have investigated the importance of 
interactions between Tet1 and O-linked N-acetylglucosamine (O-GlcNAc) 
transferase (OGT). Previous studies have demonstrated that OGT catalyzes 
the addition of O-GlcNAc to serine and threonine residues in a wide range of 
proteins (Bond & Hanover, 2015). Its activity depends on the availability of 
various metabolic molecules such as glucose, ATP, glutamine, and acetyl- 
CoA (Harwood & Hanover, 2014). OGT has been shown to stably interact 
with all three Tet proteins, and the interaction of OGT with TET proteins has 
been reported to influence histone modifications and gene expression (Bauer 
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et al., 2015; Chen et al., 2012; Deplus et al., 2013; Shi et al., 2013; Vella et 
al., 2013). However, the mechanism of the TET-OGT interaction is unclear 
and how this interaction affects TET enzymatic activity in vivo remains an 
open question. 
 
 
Given that Tet1 can compensate the loss of Tet2 and Tet3 during the 
emergence of HSCs, we asked whether a Tet1 mutant protein with impaired 
TET-OGT could to rescue the HSC phenotypes in tet2/3DM larvae. The 
Panning lab mapped the interaction between TET1 and OGT to a small C- 
terminal region of TET1 and demonstrated that OGT binding enhances the 
catalytic activity of TET1 in vitro. As part of a collaboration, we asked whether 
the potential for Tet1 to rescue HSC phenotypes in tet2/3DM larvae was also 
dependent on its capacity to interact with OGT. Mutation in D2018 of TET1 
was known to abolish its OGT interaction capacity in vitro. To test whether 
this mutation also abolished in vivo activity, embryos derived from 
intercrosses between tet2mk17/mk17, tet3mk18/+ adults were injected with either 
D2018A mutant Tet1 RNA or wild-type Tet1 RNA. The embryos were 
subsequently collected at 30hpf and assessed for runx1 by WISH. We found 
that while overexpressing wild-typeTet1 RNA significantly increased runx1 
expression in the DA of tet2/3DM larvae, overexpressing Tet1 D2018A mRNA 
failed to rescue runx1 expression in double mutants (Figure 26A-26B). 
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Consistent with this observation, we noted that the tet2/3DM larvae injected 
with wild-type Tet1 RNA exhibited a modest increase in the global 5hmC 
levels relative to the uninjected controls, however, the elevated global 5hmC 
levels were lost in the tet2/3DM injected with D2018A mutant Tet1 RNA (Figure 
26C). Overall, these data suggest that TET-OGT interaction is 
required for Tet1 to compensate the loss of Tet2 and Tet3 in the HSC 
development. 
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Figure 26. The interaction with OGT is required for TET1 activity in the 
zebrafish embryo 
 
(A) WISH for the HSC marker runx1 expression in the dorsal aorta of wild type or tet2/3
DM 
zebrafish embryos, uninjected or injected with mRNA encoding Tet1 wild type or D2018A. 
(B) Percentage of embryos with high runx1 expression along the dorsal aorta. (C) 
Methylene blue staining and dot blot for 5hmC on genomic DNA isolated from larvae at 
32hpf. 
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CHAPTER THREE: DISCUSSION 
 
 
1.1 TET requirements in normal zebrafish development 
 
Our systematic analysis of Tet mutant phenotypes revealed Tet2 and Tet3 to 
be the major 5mC dioxygenases in the zebrafish embryo. To date, a number of 
studies in mouse have focused on Tet1 and Tet2, likely due to the fact that 
these are the only TET orthologs expressed in ESCs (Wu and Zhang, 2011). 
Nonetheless, Tet3 is up regulated upon differentiation of ESCs and is highly 
expressed in many differentiated primary tissues (Dawlaty et al., 2013; Li et al., 
2015). A more recent study showed that acute deletion of Tet2 and Tet3  in 
hematopoietic compartment leads to a more aggressive myeloid leukemia 
phenotype compared to Tet2 single mutant mice (An et al., 2015). Our analysis 
of zebrafish tet mutants, combined with the phenotype of conditional Tet2/3 
mutant mice and the poor differentiation capacity of Tet1/2/3 mutant ESCs, 
suggest that Tet2 and Tet3 have important overlapping requirements  in 
ensuring normal vertebrate development (Dai et al., 2016; Dawlaty et al., 2014). 
 
 
Intriguingly, while at least Tet3 is maternally deposited in mouse, few, if any, 
tet transcripts are detected in RNA-seq data from 2-cell stage zebrafish 
embryos and 5hmC is not detected in the zebrafish embryo by 
immunofluorescence until the bud stage (Almeida et al., 2012; Gu et al., 2011). 
These observations imply that mRNAs encoding the TET enzymes are 
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not maternally deposited in zebrafish and suggest that, in contrast to mammals, 
the zebrafish genome does not contain significant amounts of 5hmC prior to 
segmentation. Zebrafish do not undergo the same TET dependent erasure and 
reestablishment of global 5mC patterns observed during mammalian 
preimplantation development, providing one potential explanation for this 
distinction (Jiang et al., 2013; Potok et al., 2013). The lack of maternal 
deposition and limited dependency on TET enzymes during the first 24 hours 
post fertilization make zebrafish a powerful system for examining TET 
requirements in later developmental processes, including those associated 
with tissue specific development and differentiation. 
 
 
 
1.2 Roles for Tet2 and Tet3 in hematopoietic stem cell emergence 
 
A focus of this thesis was to examine requirements for Tet2/3 during embryonic 
stages of hematopoietic development. The earliest stages of definitive 
hematopoiesis also appear unaffected in Tet2 single mutant mice and 
zebrafish, although diminished expression of c-myb but not runx1 was 
observed in the dorsal aorta of tet2 morpholino injected zebrafish embryos (Ge 
et al., 2014; Gjini et al., 2014; Ko et al., 2011; Kunimoto et al., 2012; Li et al., 
2011b; Moran-Crusio et al., 2011; Quivoron et al., 2011; Shide et al.,  2012; 
Solary et al., 2014). In genetic models, loss of Tet2 eventually leads to an 
expansion of hematopoietic progenitor cells in the bone marrow and skewed 
myeloid differentiation (Gjini et al., 2014; Ko et al., 2011; Li et al., 
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2011b; Moran-Crusio et al., 2011). However, the long latency that precedes 
these phenotypes suggests secondary somatic mutations may be a 
contributing factor. Meanwhile, acute deletion of Tet2 and Tet3 in 
hematopoietic precursor cells leads to a highly aggressive myeloid leukemia 
phenotype with 100% penetrance (An et al., 2015). 
 
In contrast to these later hematopoietic phenotypes, we find that combined 
mutation of tet2/3 causes an early loss of definitive blood cells, resulting from 
compromised HSC production. Importantly, abnormalities in HSC development 
occurred in embryos that were morphologically quite normal,  and had normal 
expression of vascular markers. The relatively normal development of tet2/3DM 
larvae supports a specific role for tet2 and tet3 in regulating transcription of the 
embryonic HSC developmental program rather than a more generalized role in 
regulating global transcription. The different HSC phenotypes we observed 
compared to the Tet2/3 mutant mice might likely reflect different requirements 
for Tet2/3 at different stages during HSC development. While studies by An 
and colleagues conditionally mutated Tet2 and Tet3 in hematopoietic 
compartment, HSCs had been formed before Tet2 and Tet3 were depleted. 
Therefore, their system is better suited to study the requirements for Tet2/3 in 
regulating the proliferation and differentiation of HSCs. Our study, on the other 
hand, used whole animal tet2/3 double mutant, which enabled the study of the 
earliest requirements for Tet2 and Tet3 in  HSC development. 
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Compared to tet1, both tet2 and tet3 transcripts are relatively enriched in the 
DA of the developing zebrafish embryo (Ge et al., 2014). This expression 
pattern provides a potential explanation for the specific overlapping Tet2/3 
requirements in HSC production. Analysis of double mutant larvae revealed a 
combined requirement for tet2/3 in regulating Notch signaling in the hemogenic 
endothelium, suggesting a role for 5hmC in the specification or early function 
of this tissue. Enrichment of 5hmC has been reported at Notch receptor and 
ligand genes in other tissues, but the functional significance of these changes 
has not been determined (Terragni et al., 2014). Intriguingly, we find Notch 
signaling to be relatively intact in other tissues of tet2/3DM larvae, indicating that 
Tet2/3 are likely be involved in fine-tuning the activation of this pathway in 
select cell types. Notch signaling is essential for HSC development in 
vertebrates, and has been implicated in both specification of the dorsal aorta 
and downstream HSC production (Jagannathan-Bogdan and Zon, 2013; 
Robert-Moreno et al., 2005). Tet2/3 appear to be dispensable for Notch 
regulation of arterial specification, as we observe normal expression of the 
arterial marker ephrinb2 in tet2/3DM larvae. Instead, disruption in Notch 
signaling in the hemogenic endothelium favors a select requirement for Tet2/3 
in the regulation of HSC specification. This model is consistent with the 
downstream disruption of the gata2b/scl/runx1 transcriptional network 
observed in tet2/3DM larvae and our observation that reintroducing scl or gata2b 
mRNA can rescue HSC production in double mutants. Notably, Notch 
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regulation is dispensable for scl expression during the primitive wave of 
hematopoiesis, which is consistent with the normal scl expression observed in 
tet2/3DM primitive erythrocytes (Burns et al., 2005; Kim et al., 2013). We also 
find that reintroducing Notch signaling in vascular endothelial cells is sufficient 
to rescue the de novo emergence of HSC in the tet2/3DM larvae. However, we 
observe that Notch signaling in the kdrl+ vasculature alone is not sufficient to 
support the HSC pools at the later stage. It is plausible that other pathways 
regulated by Tet2/3 are required for the seeding, migration, or proliferation of 
HSCs after they are emerged from the dorsal aorta. Alternatively, the vascular 
niche in the caudal hematopoietic tissue may be disrupted due to the deficiency 
of Tet2 and Tet3, leading to the diminished HSPC population at the later stage. 
 
 
 
1.3 Potential links between impaired primitive hematopoiesis and loss of 
hematopoietic stem cells in tet2/3DM larvae 
The RNA sequencing results reveal an unexpected down-regulation of 
inflammatory genes in the vascular endothelial cells of the tet2/3DM prior to  the 
onset of EHT. It has been shown that hemogenic endothelium is enriched for 
inflammatory signaling, and Notch signaling functions downstream of 
inflammatory signaling to regulate the emergence of HSCs (Espín-Palazón  et 
al., 2014; He et al., 2015). It is likely that Tet2/3 regulate inflammatory signaling  
in  the  hemogenic  endothelium  to  ensure  the  EHT  process. We 
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demonstrate one possible way that Tet2/3 control the inflammatory signaling 
by facilitating the development of primitive myeloid cells, as they can act as a 
source of inflammatory signals. 
 
Defects in primitive hematopoiesis following antisense morpholino depletion  of 
tet2 in zebrafish and impaired differentiation of primitive embryonic/yolk sac 
progenitors following shRNA depletion of TET2 in human ESCs have been 
previously reported (Ge et al., 2014; Langlois et al., 2014). However, these 
results are difficult to reconcile with the normal primitive hematopoiesis 
observed in published mouse and zebrafish models of Tet2 mutation (Gjini et 
al., 2014; Ko et al., 2011; Kunimoto et al., 2012; Li et al., 2011b; Moran- Crusio 
et al., 2011; Quivoron et al., 2011; Shide et al., 2012; Solary et al., 2014). While 
it is difficult to definitively address the discrepancies between these studies, 
both shRNA and antisense morpholino technologies can be susceptible to off 
target effects (Kok et al., 2015; Scherer and Rossi, 2003). Similar to other 
published studies of Tet2 mutants, our initial analysis  indicates an overtly 
normal primitive hematopoiesis in tet2/3DM larvae as assessed by expression 
of gata1, scl and pu.1 at 25 hpf by WISH. However, subsequent study reveals 
a subtle primitive defect in tet2/3DM larvae as the number mfap4-expressing 
primitive macrophages is significantly less compared to siblings. This 
discrepancy may reflect the different populations of primitive myeloid cells 
marked by pu.1 and mfap4 probes. Combined with RNA sequencing data, we 
hypothesize that reduced csf3a/3b expression in 
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the tet2/3DM negatively affects the primitive myeloid cell population. It will be 
interesting to study whether the functions of primitive myeloid cells are also 
affected in the tet2/3DM larvae and whether Tet2/3 directly regulate the 
development of primitive myeloid cells 
 
 
 
1.4 Compensation between TET proteins 
Using the tet2/3DM as a platform, we find Tet1 can compensate the loss of 
Tet2/3 in the development of HSC, suggesting TET family members function 
similarly and can compensate the loss of others when expressed at sufficient 
levels. Alternatively, stimulating endogenous TET enzymatic activity by 
supplementing cofactors can achieve similar outcomes as Vitamin C treatment 
rescued the HSC phenotypes in the tet2/3DM. Indeed, previous studies have 
highlighted the use of Vitamin C to stimulate TET activity in a wide range of 
cells including mouse ES cells, embryonic fibroblasts and T regulatory cells 
(Blaschke et al., 2013; Dickson et al., 2013; Nair et al., 2016; Yue et al., 2016). 
Our animal study validates the in vivo potency of using Vitamin C to stimulate 
the activity of TET enzymes, which could have therapeutic implications. 
 
 
For example, the loss of 5hmC has been identified as a novel epigenetic 
hallmark of cancer with diagnostic and prognostic implications. In melanoma, 
loss of 5hmC is correlated with cancer progression, while rebuilding global 
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5hmC levels by overexpressing TET suppresses melanoma growth (Lian et al., 
2012). In blood cancers, TET2 is one of the most frequent mutations, and loss 
of 5hmC can be observed in the blood cells of patients with TET2 mutations. 
One promising approach in treating blood cancers is to restore TET activity, 
however, the feasibility to overexpress TET directly in patients remains unclear. 
Vitamin C treatment appears to be a tempting way to rescue the global 5hmC 
levels by stimulating endogenous TET activity in cancer  cells. In melanoma 
cells, treatment with vitamin C promoted 5hmC content and decreased 
malignancy of metastasis (Gustafson et al., 2015). In AML cell lines, vitamin C 
treatment at high concentrations induced a dose- and time- dependent 
inhibition of proliferation (Park, 2013). At lower concentrations, Vitamin C 
treatment had a synergistic inhibition of AML cell proliferation with DNMTi 
treatment, which is likely the results of both passive DNA demethylation by 
DNMTi and active conversion of 5mC to 5mC by TET enzymes (Liu et al., 
2016). Interestingly, while many vertebrate species are able to synthesize 
vitamin C, some species, such as teleost fish, primates, guinea pigs, as well as 
some bat and bird species have lost the capacity to synthesize it (Drouin, 
Godin, & Page, 2011). This makes zebrafish an ideal in vivo model to advance 
the application of using vitamin C as a cancer therapy. One caveat of our study 
is that the concentration of vitamin C we used in our experiments was the 
concentration in fish water, which might not be the concentration  at  
physiological  levels.  Further  study  should  measure  the 
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physiological levels of vitamin C to better translate the study in fish into 
therapeutics. 
 
 
 
1.5 Applications of using the tet2/3DM as a platform to study novel regulators 
 
 
of TET proteins 
Finally, we demonstrate that tet2/3DM larvae are an efficient platform to study 
novel regulators of TET proteins. From a forward approach, we performed a 
chemical suppressor screen using the expression of runx1 as the readout.  The 
chemical screen revealed SGI-1776, M344, and LAQ824 were able to rescue 
the runx1 expression in the tet2/3DM, suggesting these  chemicals might 
regulate the expression or enzymatic activity of endogenous Tet1. Further 
experiment showed that LAQ824 treatment led to a small but consistent 
increase in the tet1 expression, however, the up-regulation of tet1 was not 
statistically significant. The data suggest that either tet1 upregulation was only 
in a subset of cells diluted out in our whole embryo analysis or that other 
mechanism mediate the suppression of HSC loss in tet2/3DM larvae.  The pilot 
chemical screen was performed at a low concentration (15mM) to ensure the 
overtly normal development of fish. However, there may be merit in repeating 
this screen at additional concentrations to identify candidate chemicals that 
regulate tet1 expression or activity with different potency. 
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In a second approach, we tested the importance of TET-OGT interaction in 
regulating Tet1 enzymatic activity using our tet2/3DM platform. Our result that 
wild type Tet1, but not Tet1 carrying a mutation that can impair interaction 
with OGT, can rescue HSC development tet2/3DM larvae. This finding 
suggests that OGT regulation of TET enzymes plays an important role in 
development. While previous studies have shown that TET proteins can 
recruit OGT to specific regions of the genome, regulating the site-specific 
gene expression by modifying local histone coding (Chen et al., 2012; Deplus 
et al., 2013; Vella et al., 2013), our results revealed an additional function of 
the TET-OGT interaction, which is to regulate the enzymatic activity of Tet1 
proteins. It will be interesting to examine whether the TET-OGT interaction is 
required for Tet2 and Tet3 enzymatic activity. Together, we show that the 
tet2/3DM larvae we generated can be broadly used for identifying novel Tet1 
regulators either from a forward or a reverse approach. 
 
 
 
1.6 Conclusions and Significance 
 
Collectively, the research described in this thesis uncovers a requirement for 
TET regulation of 5hmC in zebrafish development and the emergence of 
HSC. A deeper understanding of how HSC generation is regulated in vivo is 
expected to facilitate the in vitro production of HSCs for therapeutic purposes. 
Importantly, our results identify regulation of 5hmC as an additional variable 
to be considered in the optimization of protocols for HSC differentiation from 
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pluripotent progenitors. This observation may be of particular relevance given 
recent data highlighting the impact of cell culture conditions on global 5hmC 
levels (Blaschke et al., 2013; Nestor et al., 2015; Yin et al., 2013). 
Additionally, searching for a cure for blood cancers calls for a better system to 
evaluate the pathways involved in oncogenesis. Our tet2/3DM system has 
proven to be an efficient platform to study and test regulators of TET proteins. 
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CHAPTER FOUR: METHODS 
 
 
 
Zebrafish maintenance 
 
Zebrafish maintenance and breeding were conducted under full animal use 
and care guidelines with approval by the institutional animal care and use 
committee of the Memorial Sloan Kettering Cancer Center. Embryos and 
adult zebrafish were raised under standard conditions at 28.5°C. 
 
 
TALEN and CRISPR/Cas mutagenesis 
 
TALEN sequences were selected using Targeter 2.0 software (Doyle et al., 
2012). TAL repeat assembly was achieved using the Golden Gate assembly 
method and assembled repeats were integrated into the GoldyTALEN 
scaffold (Bedell et al., 2012; Cermak et al., 2011). Assembled vectors served 
as templates for in vitro mRNA transcription using the T3 mMessage 
mMachine kit (Ambion) according to manufacturer’s instructions. 50-100 pg of 
mRNA was injected into wild-type embryos at the one-cell stage. 
 
 
CRISPR/Cas system was adopted from Chen and Wente lab (Jao, Wente, & 
Chen, 2013). CRISPR gRNAs were designed using MacVector and 
incorporated in to the pT7-gRNA core. Assembled vectors served as 
templates for in vitro transcription using the T3 RNA polymerase. Cas9 RNAs 
were synthesized from pT3TS-nCas9n plasmid using the T3 mMessage 
84  
mMachine kit (Ambion). Cas9 RNAs and gRNAs were co-injected into 
zebrafish embryos at the one-cell stage. 
 
 
Recovery of tet mutant zebrafish 
 
Embryos injected with mRNA encoding TALEN pairs that targeted each tet 
gene were separately raised to adulthood and crossed to wild type. Founders 
carrying germline transmissible mutations were identified by isolating DNA 
from pooled larval progeny. DNA was PCR amplified and digested using 
diagnostic restriction enzymes within the region targeted for mutation. The 
presence of a resistant band indicated that some larval progeny from the 
tested founder were heterozygous for a mutation in the targeted region. 
Additional progeny from the identified founder were then raised to adulthood 
and heterozygotes were identified using the same genotyping strategy on 
DNA isolated from caudal fin tissue. The PCR fragment was then cloned and 
sequenced to identify the exact lesion. Adults carrying mutations that 
generated predicted frame-shift events were crossed to wild-type adults to 
generate stable lines (Figure 27A-27H). 
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Figure 27. Recovery of tet mutant zebrafish 
 
(A) tet1 TALEN design. Sequences targeted by the left and right TALEN monomers 
are included in capitals. The HinfI diagnostic restriction site located within the spacer 
region of the wild-type sequence is underlined. (B) Schematic indicating the 4 base 
pair deletion in the tet1
mk16 
allele. Amino acids encoded by the wild-type sequence 
are indicated at the top. The Hinf1 restriction site, which is destroyed in tet1
mk16
, is 
underlined. (C) Representative gel genotyping larvae for the tet1
mk16 
mutation. 
Following PCR amplification of the targeted region, only the wild-type tet1 allele can 
be digested by Hinf1. (D) tet2 TALEN design. Sequences targeted by the left and 
right TALEN monomers are included in capitals. The BsaI diagnostic restriction site 
located within the spacer region of the wild-type sequence is underlined. (E) 
Schematic indicating the 4 base pair deletion in the tet2
mk17 
allele. Amino acids 
encoded by the wild-type sequence are indicated at the top. The BsaI restriction site, 
which is destroyed in tet2
mk17
, is underlined. (F) Representative gel genotyping larvae 
for the tet2
mk17 
mutation. Following PCR amplification of the targeted region, only the 
wild-type tet2 allele can be digested by BsaI. (G) tet3 TALEN design. Sequences 
targeted by the left and right TALEN monomers are included in capitals. The Fnu4HI 
diagnostic restriction site located within the spacer region of the wild-type sequence 
is underlined. (H) Schematic indicating the 14 base pair deletion in the tet3
mk18 
allele. 
Amino acids encoded by the wild-type sequence are indicated at the top. The 
Fnu4HI restriction site, which is destroyed in tet3
mk18
, is underlined. (I) 
Representative gel genotyping larvae for the tet3
mk18 
mutation. Following PCR 
amplification of the targeted region, only the wild-type tet3 allele can be digested by 
Fnu4HI. 
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WISH 
 
WISH was performed as described (Thisse and Thisse, 2008). For all probes 
except gata2b, 10% dextran sulfate was added to the hybridization buffer. 
 
 
RNA synthesis and microinjection 
 
The human TET3 vector used for mRNA production has been previously 
described (Ko et al., 2013). The human TET2 ORF corresponding to 
Genebank: NM_001127208 was amplified from SY5Y cDNA and following 
sub-cloning, was introduced into the pEF1/V5-His vector (Invitrogen) to allow 
for in vitro transcription. Mutant TET2 (H1382Y, D1384A) was generated 
using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent). 
pExpress-1-gata2b was purchased from Transomic Technologies. For scl-β, 
RT-PCR amplified scl-β cDNA with sequence corresponding to Genbank: 
EF488003 was cloned into pCS2+. Sequences of all clones were confirmed 
by conventional DNA sequencing. Tet1 plasmid was purchased from 
Addgene. Mutant Tet1 D2018A was obtained from the Panning lab. In all 
cases, capped RNA was synthesized using mMessage mMachine (Ambion) 
with SP6 or T7 polymerase as appropriate to the vector. For each 
experimental condition, mRNA was injected into at least fifty embryos 
derived from tet2mk17/mk17, tet3mk18/+ intercrosses. 
88  
 
5hmC Dot Blot 
 
Genomic DNA was isolated from larvae at 30hpf by phenol-chloroform 
extraction and ethanol precipitation. Following RNase treatment and 
denaturation, 2-fold serially diluted DNA was spotted onto nitrocellulose 
membranes. Cross-linked membranes were incubated with 0.02% methylene 
blue to validate uniform DNA loading. Membranes were blocked with 5% BSA 
and incubated with anti-5hmC antibody (1:10,000; Active Motif) followed by a 
horseradish peroxidase-conjugated antibody (1:15,000; Active Motif). Signal 
was detected using the ECL Prime Detection Kit (GE). 
 
 
Time-lapse confocal microscopy 
 
Embryos were anaesthetized with 0.02% tricaine and embedded in 0.5% low- 
melt agarose. Embryos were scanned using a SP8 confocal microscope 
(Leicia) at 28.5°C. Confocal z-stacks were acquired every 7 to 10 minutes 
between 30 and 46 hpf. Approximately 25 planes were collected per time 
point at a spacing of 3 µm. Data was analyzed using Imaris software and 
exported in QuickTime. All confocal planes were sequentially analyzed to 
identify changes in cell morphology consistent with EHT and to identify 
nuclear fragmentation events. 
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       TP1:GFP imaging and quantification 
 
Mounted samples were scanned using an SP8 confocal microscope (Leica) 
using 40X water immersion objective at 26 hpf. For each image, 
approximately 60 planes were captured at a spacing of 0.38um. Data 
processed using Imaris software and quantified using ImageJ. 
 
 
Fluorescent activated cell sorting 
 
Zebrafish larvae carrying kdrl:mCerry transgene were digested with 0.25% 
Trypsin-EDTA at 37°C for 20-30 minutes before adding DMEM10 to stop the 
digestion. Cell pellets were collected after centrifugation at 500g for 10 
minutes and subsequently re-suspended in 500ul DMEM. The re-suspended 
cell solution was filtered by passing through 5ml polystyrene round-bottom 
tube with cell-strainer cap (12 × 75mm). Cell sorting was performed by the 
MSKCC Flow Cytometry Core Facility. 
 
 
RNA isolation and qRT-PCR 
 
Zebrafish larvae were lysed in Trizol and total RNA was isolated by ethanol 
precipitation. The cDNAs were synthesized using GoScript Reverse 
Transcription system (Promega, A5000). Quantitative real-time PCR was 
performed in duplicate using Power SYBR Green PCR Master Mix (Applied 
Biosystems, #4367659) on the ABI PRISM 7500 Real Time PCR System 
(Applied Biosystems) using the following parameters:  12 min at 95°C 
followed by 40 cycles of 20s at 95°C, 30s at 55°C, and 30s at 70°C.
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      RNA sequencing 
 
Mutant and sibling zebrafish larvae carrying kdrl:mCerry were lysed and 
mCherry+ cells were collected for RNA sequencing. On average 8,000 
mCherry+ cells were harvested from 30 larvae for each sample within the 
triplicates. Sample cells were re-suspended in Trizol LS reagent for RNA 
extraction. We set 40 millions reads, 100bp paired ends as the parameters of 
the RNA sequencing. cDNAs were amplified using SMARTer cDNA synthesis 
kit (Clontech). The RNA extraction and RNA sequencing were performed by 
the MSKCC Integrated Genomic Operating Core Facility. 
 
 
5mC analysis 
 
Genomic DNA was prepared from kdrl:mCherry positive FACS sorted cells 
isolated from pools of roughly 40 mutant or sibling larvae at 28 hpf. DNA was 
bisulfite converted using the EZ methylation kit (Zymo-Research). PCR 
products were cloned into pGEM-T Easy Vector System (Promega) and 
sequenced.  Data were analyzed by QUMA (Kumaki et al., 2008). 
 
Data Quantification and Statistical analysis 
 
Quantification data were presented as mean ± SEM. The Student unpaired 2- 
tailed t-test was used for statistical analysis using Microsoft Excel. 
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SUMMARY
The Tet family of methylcytosine dioxygenases
(Tet1, Tet2, and Tet3) convert 5-methylcytosine to
5-hydroxymethylcytosine. To date, functional over-
lap among Tet family members has not been
examined systematically in the context of embry-
onic development. To clarify the potential for over-
lap among Tet enzymes during development, we
mutated the zebrafish orthologs of Tet1, Tet2, and
Tet3 and examined single-, double-, and triple-
mutant genotypes. Here, we identify Tet2 and Tet3
as the major 5-methylcytosine dioxygenases in the
zebrafish embryo and uncover a combined require-
ment for Tet2 and Tet3 in hematopoietic stem cell
(HSC) emergence. We demonstrate that Notch
signaling in the hemogenic endothelium is regulated
by Tet2/3 prior to HSC emergence and show that
restoring expression of the downstream gata2b/
scl/runx1 transcriptional network can rescue HSCs
in tet2/3 double mutant larvae. Our results reveal
essential, overlapping functions for tet genes during
embryonic development and uncover a requirement
for 5hmC in regulating HSC production.
INTRODUCTION
In vertebrate species, the epigenetically modified base 5-meth-
ylcytosine (5mC) is associated with transcriptional repression
and is essential for normal development (Goll and Bestor,
2005). The mechanisms that establish and maintain 5mC are
well defined, but less is known about how 5mC is removed
(Wu and Zhang, 2011). The ten-eleven translocation proteins
(Tet1, Tet2, and Tet3) comprise a family of 2-oxoglutarate- and
Fe(II)-dependent dioxygenases that convert 5mC to 5-hydroxy-
methylcytosine (5hmC) and its oxidative derivatives 5-formylcy-
tosine (5fC) and 5-carboxylcytosine (5caC) (He et al., 2011;
Tahiliani et al., 2009). Growing evidence suggests that conver-
sion of 5mC to 5hmC and its derivatives can provide a first
step toward DNA demethylation through active base excision
or passive dilution of oxidized bases (Kohli and Zhang, 2013).
Consistent with a role in regulating gene expression through
DNA demethylation, 5hmC levels are most abundant in euchro-
matic regions, including transcription start sites, enhancers, and
exons (Pastor et al., 2011; Stroud et al., 2011; Williams et al.,
2011).
Individually, homozygous mutation of Tet1, Tet2, or Tet3 is
compatible with mouse embryonic development, although Tet3
mutant mice die perinatally (Kohli and Zhang, 2013). Conditional
deletion of Tet3 in oocytes results in delayed demethylation of
the paternal genome and increased developmental failure, but
viable pups can be recovered (Gu et al., 2011; Inoue et al.,
2015). In contrast to single mutants, embryonic stem cells
(ESCs) mutated for all three Tet genes contribute poorly to chi-
meras, suggesting that Tet family members have overlapping
functions in promoting embryonic development (Dawlaty et al.,
2014). Tet1/2 double-homozygous-mutant mice can survive
into adulthood, but other Tet mutant combinations have yet to
be described (Dawlaty et al., 2013).
Tet regulation appears to be of particular importance in the
hematopoietic lineage. TET1 was first identified as a fusion
partner of the mixed lineage leukemia (MLL) gene in acute
myeloid leukemia and has essential oncogenic roles in MLL re-
arranged leukemias (Huang et al., 2013; Lorsbach et al., 2003).
Moreover, Tet1 mutations promote increased self-renewal of
progenitor B cells and susceptibility to B cell lymphoma in
mice (Cimmino et al., 2015). Mutations in TET2 are common
in human myeloid malignancies, and Tet2 mutation promotes
myeloid transformation in mice and zebrafish (Gjini et al.,
2015; Ko et al., 2011; Kunimoto et al., 2012; Li et al., 2011b;
Moran-Crusio et al., 2011; Quivoron et al., 2011; Shide et al.,
2012; Solary et al., 2014). Consistent with a role in promoting
myeloid malignancy, Tet2 mutation causes increased numbers
of hematopoietic progenitor cells in the bone marrow and
skewed differentiation toward the myelomonocytic lineage in
mice (Ko et al., 2015). Similarly, human cord blood cells
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depleted for TET2 and cells isolated from leukemia patients
bearing TET2 mutations exhibit an increase in myeloid-lineage
differentiation at the expense of the erythroid-lineage (Madzo
et al., 2014; Pronier et al., 2011). Recently, mutation of Tet3
was shown to cause minor decreases in the absolute number
of hematopoietic stem cells (HSCs) in the mouse bone marrow,
while numbers of myeloid, erythroid and B lymphoid cells were
unaffected (Ko et al., 2015).
While the importance of Tet regulation in the adult hematopoi-
etic system is clear, less is known about requirements for Tet
genes during early stages of hematopoietic development. Re-
ports using antisense morpholino depletion in zebrafish and
shRNA depletion in human ESCs have implicated Tet2 in the
regulation of primitive hematopoiesis; but, these results are at
odds with the normal primitive hematopoiesis observed in Tet2
mutant mice and zebrafish (Ge et al., 2014; Gjini et al., 2015;
Ko et al., 2015; Langlois et al., 2014). The de novo generation
of HSCs during the definitive wave of hematopoiesis also ap-
pears normal in Tet2 mutant mouse and zebrafish embryos;
however, the potential for additional Tet enzymes to contribute
to HSC emergence during embryonic development has not
been experimentally addressed in mutant animals (Gjini et al.,
2015; Ko et al., 2015).
The zebrafish genome encodes single well-conserved ortho-
logs of Tet1, Tet2, and Tet3 (Almeida et al., 2012). To define the
requirements for these genes during development, we gener-
ated stable lines carrying mutations in each of the zebrafish
tet orthologs and derived single-, double-, and triple-homozy-
gous-mutant larvae representing all genetic combinations. In
this study, we demonstrate that Tet2 and Tet3 are the major
5mC dioxygenases in the zebrafish embryo and that they
have overlapping functions in promoting normal development.
In addition, we describe a combined requirement for tet2 and
tet3 in the de novo generation of HSCs in the embryo, and
we demonstrate the importance of tet2/3 for Notch signaling
and downstream expression of the gata2b/scl/runx1 transcrip-
tional program in the hemogenic endothelium. Our results pro-
vide a comprehensive analysis of tet mutants in the developing
zebrafish embryo and identify requirements for Tet regulation in
the early function of the hemogenic endothelium. These results
underscore the importance of epigenetic regulation for the
generation of HSCs and identify regulation of 5hmC as an
additional variable to be considered in therapeutic applications
such as the in vitro differentiation of HSCs from pluripotent
precursors.
RESULTS
TALEN-Induced Mutations Reveal Overlapping
Requirements for tet2 and tet3 in the Zebrafish Embryo
To systematically define requirements for 5hmC during develop-
ment, we introduced mutations into the zebrafish orthologs
of Tet1, Tet2, and Tet3 using TAL effector nucleases (TALENs)
(Li et al., 2011a; Sander et al., 2011). RNAs encoding TALENs
that targeted each gene were separately injected into one-cell-
stage embryos, andwe recovered individuals harboring germline
transmissible mutations in each of the three genes. The recov-
ered tet2mk17 allele deletes 4 bp in exon 8. This deletion results
in a frameshift, causing early termination one amino acid 30 of
an essential iron-binding residue (Figures 1A and 1B; Figures
S1D–S1F). The tet1mk16 and tet3mk18 alleles harbor 4-bp and
14-bp deletions, respectively, in the last coding exon. In addition
to causing frameshift and premature termination, these deletions
eliminate sequence encoding a C-terminal arginine residue that
is required for 2-oxoglutarate binding (Hu et al., 2013) (Figures
1A and 1B; Figures S1A–S1C and S1G–S1I). Loss of specific
residues involved in cofactor binding and catalysis is predicted
to similarly compromise the dioxygenase activity of all three
enzymes.
Modest (<3-fold) reductions in total 5hmC were observed in
larvae that were homozygous mutant for tet1, tet2, or tet3
(Figure 1C). More considerable reductions in 5hmC were
observed in double mutants, with the tet2mk17/mk17, tet3mk18/mk18
double-mutant (tet2/3DM) combination producing the most dra-
matic decrease (>30-fold) (Figure 1C). 5hmC levels were further
reduced in tet1/2/3 triple-mutant (tet1/2/3TM) larvae, indicating
that all three mutated genes encode proteins that are compro-
mised for catalytic activity (Figure 1D). The enhanced loss of
5hmC in tet2/3DM larvae compared to other double-mutant
combinations argues that Tet2 and Tet3 are the predominant
5mC oxidases in the zebrafish embryo and that they func-
tion redundantly to promote the formation of 5hmC during
development.
Zebrafish that were homozygous for mutations in tet1, tet2, or
tet3 were viable to adulthood, as were tet1/2 and tet1/3 double-
homozygous mutants. In contrast, combined mutation of tet2
and tet3 was not compatible with survival beyond the larval
period. The tet2/3DM larvae were morphologically indistinguish-
able from wild-type controls during the first 24 hr postfertilization
(24 hpf), but subtle abnormalities in brain development emerged
on the second day postfertilization (2 dpf). By 36 hpf, smaller
eyes, abnormal brain morphology, altered pigmentation, and a
modest curvature of the trunk were apparent in 25% of larvae
derived from intercrosses between tet2mk17/mk17, tet3mk18/+
adults (Figure 1E). Genotyping (n = 20) confirmed that the
morphologically abnormal embryos all carried homozygous
mutations in both tet2 and tet3, demonstrating a combined
requirement for the two genes in zebrafish development. Despite
the additional reduction in 5hmC, tet1/2/3TM larvae were
morphologically indistinguishable from tet2/3 double mutants
at all stages examined (Figure 1F; data not shown).
Overlapping Requirements for Tet2 and Tet3 in
Definitive, but Not Primitive, Hematopoiesis
Given the combinatorial effects of tet2 and tet3 mutation on
overall development, as well as the known roles of Tets in later
stages of hematopoiesis, we tested whether tet2 and tet3 had
overlapping roles in regulating hematopoiesis during embry-
onic development. Development of non-HSC-derived primitive
erythroid and myeloid cells was normal in tet2/3DM larvae and
tet2mk17/mk17 siblings as assessed by expression of gata1, scl,
and pu.1 at 25 hpf by whole-mount in situ hybridization (WISH)
(Figures 2A–2I). In contrast, expression of HSC-dependent
definitive blood cell markers was dramatically reduced in
tet2/3DM larvae compared to stage-matched wild-type controls.
While mature rag1-positive T cells were readily observed in the
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thymus of wild-type larvae at 5 dpf, rag1-positive cells were ab-
sent from the corresponding region of tet2/3DM larvae (Figure 3A
and 3B). Similarly, the Tg(lysC:GFP) transgenic line, which
labels definitive granulocytes (Hall et al., 2007), produced a clear
fluorescent signal in blood from wild-type larvae at 6 dpf, but
fluorescent cells were not detected in tet2/3DM larvae at this
stage (Figures 3C and 3D).
The loss of differentiated definitive blood cells in tet2/3DM
larvae can be attributed to a defect in HSC development. During
normal embryonic development, HSCs emerge from the hemo-
genic endothelium in the ventral wall of the dorsal aorta (DA).
In tet2/3DM larvae, we found that expression of the HSC-associ-
ated genes runx1 and c-myb was reduced in the DA at 36 hpf,
whereas runx1 expression in tet2 and tet3 single homozygous
mutant larvae was indistinguishable from wild-type (Figures
3E–3M). Moreover, in tet2/3DM larvae, c-myb positive hemato-
poietic stem and progenitor cells (HSPCs) could not be detected
in the caudal hematopoietic tissue (CHT) niche, a secondary,
transient site for HSC amplification (Figures S2A–S2F). Impor-
tantly, runx1 expression was rescued by injecting mRNA en-
coding either human TET2 or TET3 into one-cell-stage embryos
derived from tet2mk17/mk17, tet3mk18/+ intercrosses (Figure 3N).
Injection of mRNA encoding a catalytically dead version of
TET2 failed to rescue wild-type levels of runx1 expression,
Figure 1. Mutation of Zebrafish tet1, tet2,
and tet3
(A) Schematic illustrating early termination
caused by TALEN mutations in zebrafish tet1,
tet2, and tet3. Red octagons indicate the position
of early termination signals. Yellow bars indicate
conserved iron binding residues, and the green
bar indicates the arginine required for 2-ox-
oglutarate binding.
(B) Schematic depicting deleted bases in zebrafish
tet1, tet2 and tet3. Corresponding amino acid
sequences for the wild-type allele are included,
with residues required for cofactor binding or
catalysis indicated in red.
(C) Dot blot for 5hmC on genomic DNA isolated
from larvae at 5 dpf. Numbers indicate the
mutated tet gene(s) in each sample. Sc indicates
DNA isolated from Saccharomyces cerevisiae.
Horizontal rows depict 3-fold serial dilutions
of DNA.
(D) Dot blot for 5hmC on genomic DNA isolated
from larvae at 5 dpf including DNA isolated from
tet1/2/3TM larvae.
(E) Lateral views of a representative wild-type
larva, a tet2/3DM larva and a sibling larva derived
froma tet2mk17/mk17, tet3mk18/+ intercross at 36 hpf.
(F) Lateral viewsof a representativewild-type larva,
a tet2/3DM larva and tet1/2/3TM larva at 3 dpf.
All scale bars indicate 500 mM. See also Figure S1.
directly implicating the 5mC dioxygenase
activity of TET2 in regulating HSC devel-
opment (Figure 3N).
Normal vascular development, arterial
specification, and blood-flow-induced
nitric oxide (NO) signaling are known pre-
requisites for HSC development (Adamo et al., 2009; Jaganna-
than-Bogdan and Zon, 2013; North et al., 2009). WISH for the
vascular markers kdrl and cdh5 and the arterial marker efnb2a
revealed similar expression in wild-type and tet2/3DM larvae,
demonstrating the presence of an overtly intact vasculature (Fig-
ures 4A–4F). Visual inspection of tet2/3DM larvae by bright-field
microscopy showed that blood flow was grossly normal during
the first 2 days of development, and klf2a, an immediate early
responder to blood flow, was expressed at similar levels in
wild-type and tet2/3DM larvae (Figures 4G and 4H). Moreover,
while exposure to the NO agonist S-nitroso-N-acetyl-penicilla-
mine (SNAP) was sufficient to rescue runx1 expression in silent
heart (sih) morpholino-injected embryos lacking blood circula-
tion, SNAP exposure was unable to rescue runx1 expression in
tet2/3DM larvae (Figures S3A–S3E). Taken together, these results
suggest that the HSC defects observed in tet2/3DM larvae are
not secondary to defects in vascular development or aberrant
blood flow.
HSC Emergence Is Compromised in tet2/3 DM Larvae
Beginning around 32 hpf, nascent HSCs emerge from the
ventral aortic endothelium of the zebrafish embryo through a
process termed the endothelial to hematopoietic transition
(EHT) (Bertrand et al., 2010; Kissa and Herbomel, 2010). To
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test whether EHT was impacted by mutation of tet2/3, the tet2
and tet3 mutant alleles were introduced into a Tg(kdrl:Ras-
mCherry)S896, Tg(kdrl:H2B-EGFP)mu122 transgenic background
(Chi et al., 2008; Kochhan et al., 2013). In this background,
membrane mCherry and nuclear GFP are expressed in the
vascular endothelium and emergent HSCs, allowing EHT
events to be identified based on stereotypical changes in
cell morphology (Bertrand et al., 2010; Kissa and Herbomel,
2010). Prior to the onset of EHT, tet2/3DM larvae and siblings
from tet2mk17/mk17, tet3mk18/+ intercrosses exhibited similar
fluorescent labeling with the two transgenes (Figures 5A and
5B). A defined region of the DA was then monitored in tet2/3DM
larvae and sibling controls (n = 3 each) between 30 and 46
hpf by time-lapse confocal microscopy. Analysis of image
sets revealed a 4-fold reduction in the number of EHT events
detected in tet2/3DM larvae compared to siblings, indicating
that EHT is compromised in the double mutants (average
of 3 versus 13 EHT events, p = 0.001; Figures 5C and 5E;
Movie S1).
In each time-lapse sequence from tet2/3DM larvae, we also
observed between one and three cells within the DA undergoing
nuclear fragmentation (Figures 5D and 5F;Movie S2). In contrast,
fragmentation was never detected in time-lapse sequences from
siblings (Figure 5D). The nuclear fragmentation phenotype we
observed in tet2/3DM larvae is reminiscent of that described for
zebrafish embryos depleted for runx1 by morpholino injection
and suggests that a fraction of cells undergoing EHT also die
via apoptosis in the absence of tet2/3 (Kissa and Herbomel,
2010). Elevated levels of TUNEL-positive cells were not
observed in the DA or surrounding tissues of fixed tet2/3DM
larvae (n = 10, data not shown). However, apoptotic events
restricted to the few cells undergoing EHT would be difficult to
capture in fixed embryos.
Figure 2. Markers of Primitive Hematopoie-
sis Are Similarly Expressed in Wild-Type,
tet2mk17/mk17, and tet2/3DM Larvae
(A–I) Representative lateral views of wild-type
larvae compared to tet2/3DM and tet2mk17/mk17
sibling larvae derived from tet2mk17/mk17, tet3mk18/+
intercrosses.
(A–C) WISH for the primitive erythroid marker
gata1 at 25 hpf.
(D–F) WISH for the primitive erythroid marker scl at
25 hpf.
(G–I) WISH for the primitive myeloid marker pu.1 at
25 hpf. Numbers in the lower right hand corner
indicate the fraction of embryos exhibiting WISH
labeling similar to the representative image.
Scale bars indicate 500 mM.
Tet2/3 Are Required for Notch
Signaling and Expression of Key
Hematopoietic Transcription
Factors in the Hemogenic
Endothelium
The reduction in EHT events in tet2/3DM
larvae suggested a requirement for
Tet2/3 in the function or specification of
the hemogenic endothelium, which gives rise to nascent HSCs.
The hematopoietic transcription factors runx1 and scl are both
expressed in the hemogenic endothelium prior to the initiation
of EHT and are required for this process (Kissa and Herbomel,
2010; Zhen et al., 2013). By WISH, we found that expression of
both runx1 and sclwas reduced in the DA of tet2/3DM larvae prior
to HSC emergence, indicating that Tet2 and Tet3 are required to
promote the hemogenic potential of the vascular endothelium
(Figures 6A–6D). Expression of scl and runx1 is controlled in
part by the transcription factor Gata2 inmouse, and the zebrafish
genome encodes for two Gata2 paralogs that have undergone
subfunctionalization (Butko et al., 2015; Gao et al., 2013; Go¨tt-
gens et al., 2002; Pimanda et al., 2007). Zebrafish gata2a is
broadly expressed throughout the hematopoietic system and
is important for vascular morphogenesis (Zhu et al., 2011). In
contrast, zebrafish gata2b is specifically detected in the hemo-
genic endothelium and is required for runx1 expression within
this tissue (Butko et al., 2015). Consistent with the HSC-specific
phenotypes observed in tet2/3DM larvae, we found that tet2/3
mutation compromised expression of gata2b, while gata2a
expression was unaffected at similar stages (Figures 6E–6H).
Collectively, these observations identify Tet2/3 as essential
regulators of the gata2b/scl/runx1 transcriptional network in
the hemogenic endothelium.
To clarify whether disruption of gata2b/scl/runx1 transcrip-
tional program could account for the HSC defects observed in
tet2/3 double-mutant larvae, we next tested whether reintroduc-
ing mRNA encoding scl or gata2b into tet2/3DM embryos could
rescue HSC production. In-vitro-transcribed mRNA encoding
Scl or Gata2b was injected into one-cell-stage embryos derived
from tet2mk17/mk17, tet3mk18/+ intercrosses, and runx1 expression
was subsequently examined in the DA of tet2/3 double mutants
by WISH at 36 hpf. Injection of either mRNA was sufficient to
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rescue wild-type levels of runx1 expression in the DA of tet2/3DM
larvae, identifying the gata2b/scl/runx1 network as the primary
hematopoietic program regulated by Tet2/3 during HSC emer-
gence (scl: p = 0.0004, gata2b: p = 0.0008, Figures 6I–6M).
Analysis of genomic DNA from sorted vascular endothelial cells
revealed that the promoters of gata2b, runx1, and scl were simi-
larly unmethylated in wild-type and tet2/3DM larvae, suggesting
that Tet2/3 do not directly regulate expression of these genes
via promoter demethylation (Figure S4). This observation raised
the possibility that Tet2/3 act upstream of gata2b in regulating
HSC emergence. Notch signaling is required for the expression
of gata2b in the zebrafish hemogenic endothelium, and Gata2 is
adirect targetofNotchsignaling in themousedorsal aorta,making
this pathway a strong candidate for Tet2/3 regulation during HSC
emergence (Butko et al., 2015; Robert-Moreno et al., 2005). To
testwhethermutationof tet2/3disruptedNotchsignaling in thehe-
mogenic endothelium, we introduced the tet2 and tet3mutant al-
leles into a Notch reporter line, Tp1:GFP, which expresses GFP
under the control of tandemNotch responsive elements (Parsons
et al., 2009). At the whole-embryo level, wild-type and tet2/3DM
larvae exhibited similar patterns of GFP expression from the
Tp1:GFP transgene, suggesting that Notch signaling was not
globally compromised by mutation of tet2/3 (Figures S5A–S5D).
At higher resolution, morphologically wild-type embryos carrying
Figure 3. tet2 and tet3 Have Overlapping Functions in HSC Development
(A and B) WISH for rag1 at 5 dpf. Arrow indicates thymic T cells in wild-type larvae.
(C and D) GFP labeled macrophages and neutrophils in 6 dpf larvae carrying the Tg(lysC:GFP) transgene.
(E and F) WISH for the HSC marker runx1 in the DA at 36 hpf.
(G and H) WISH for the HSC marker c-myb in the DA at 36 hpf.
(I) Number of sibling and tet2/3DM embryos with wild-type (+++), reduced (++), or nearly absent (+) runx1 labeling in the DA. Numbers are representative of three
independent crosses.
(J–M) WISH for runx1 in the DA at 32 hpf.
(N) Graph indicating the percent of tet2/3DM larvae exhibiting high runx1 staining in the DA in uninjected controls or following injectionwith 100 pgmRNA encoding
TET2, TET2 H1382Y.D1384A (TET2 mutant), or TET3. Numerical data are presented as the mean ± SEM.
Numbers in the lower right corner of images indicate the fraction of larvae with WISH labeling similar to the representative image. All scale bars indicate 100 mM.
See also Figure S2.
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the Tp1:GFP transgene exhibited the expected strong expression
of Tp1:GFP along both the dorsal and ventral walls of the DA (Fig-
ure 7A). In tet2/3DM larvae, Tp1:GFP expression on the dorsal side
of the DA appeared similar to wild-type; however, expression
along the ventral wall appeared weaker and discontinuous (n =
10/11; Figure 7B). Quantification of mean GFP fluorescent inten-
sity in each region revealed a 3-fold reduction in the ratio of GFP
fluorescence in the ventral DA compared to the dorsal DA in
tet2/3doublemutants (p= 0.0002; Figure 7C). This specific reduc-
tion in GFP in the ventral DA reveals a requirement for Tet2/3 in
regulatingNotch signaling in the hemogenic endotheliumandpro-
vides a mechanistic explanation for the downregulation of gata2b
observed in tet2/3DM larvae. Taken together these results uncover
a requirement for Tet2/3 in the early function of the hemogenic
endothelium and identify Notch signaling and the downstream
expression of the gata2b/scl/runx1 transcriptional network as
key targets of Tet2/3 regulation during HSC emergence.
DISCUSSION
Our systematic analysis of tetmutant phenotypes revealed Tet2
and Tet3 to be the major 5mC dioxygenases in the zebrafish
embryo. To date, a number of studies in mouse have focused
on Tet1 and Tet2, likely due to the fact that these are the only
Tet orthologs expressed in ESCs (Wu and Zhang, 2011). None-
theless, Tet3 is upregulated upon differentiation of ESCs and is
highly expressed in many differentiated primary tissues (Dawlaty
et al., 2013; Li et al., 2015). Our analysis of zebrafish tetmutants,
combined with the survival of Tet1/2 mutant mice and the poor
differentiation capacity of Tet1/2/3 mutant ESCs, suggest that
Tet2 and Tet3 may also have important overlapping require-
ments in promoting mammalian development (Dawlaty et al.,
2013, 2014). Intriguingly, while at least Tet3 is maternally depos-
ited in mouse, few, if any, tet transcripts are detected in RNA-
sequencing data from two-cell-stage zebrafish embryos, and
5hmC is not detected in the zebrafish embryo by immunofluores-
cence until the bud stage (Almeida et al., 2012; Gu et al., 2011).
These observations imply that mRNAs encoding the Tet en-
zymes are not maternally deposited in zebrafish and suggest
that, in contrast to mammals, the zebrafish genome does not
contain significant amounts of 5hmC prior to segmentation.
Zebrafish do not undergo the same Tet-dependent erasure
and reestablishment of global 5mC patterns observed during
mammalian preimplantation development, providing one poten-
tial explanation for this distinction (Jiang et al., 2013; Potok et al.,
2013). The lack of maternal deposition and limited dependency
on Tet enzymes during the first 24 hpf make zebrafish a powerful
system for examining Tet requirements in later develop-
mental processes, including those associated with tissue spe-
cific development and differentiation.
In the current study, we examine requirements for Tet2/3 dur-
ing embryonic stages of hematopoietic development. Defects in
primitive hematopoiesis following antisense morpholino deple-
tion of tet2 in zebrafish and impaired differentiation of primitive
embryonic/yolk sac progenitors following small hairpin RNA
(shRNA) depletion of TET2 in human ESCs have been reported
(Ge et al., 2014; Langlois et al., 2014). However, these results
are difficult to reconcile with the normal primitive hematopoiesis
observed in published mouse and zebrafish models of Tet2mu-
tation (Gjini et al., 2015; Ko et al., 2011; Kunimoto et al., 2012; Li
et al., 2011b; Moran-Crusio et al., 2011; Quivoron et al., 2011;
Shide et al., 2012; Solary et al., 2014). While it is difficult to defin-
itively address the discrepancies between these studies, both
shRNA and antisense morpholino technologies can be suscepti-
ble to off-target effects (Kok et al., 2015; Scherer and Rossi,
2003). Similar to other published studies of Tet2 mutants, we
find that primitive hematopoiesis proceeds normally in the tet2
homozygous-mutant zebrafish generated by our laboratory,
and we demonstrate that combinatorial elimination of Tet2 and
Tet3 catalytic functions does not further impact primitive hema-
topoiesis. It is important to note that because the truncation mu-
tations used in this study leave N-terminal coding sequence
intact, we cannot rule out the possibility that Tet2/3 have combi-
natorial dioxygenase independent functions in regulating primi-
tive hematopoiesis.
The earliest stages of definitive hematopoiesis also appear
unaffected in Tet2 single-mutant mice and zebrafish, although
diminished expression of c-myb, but not runx1, was observed
in the DA of tet2 morpholino-injected zebrafish embryos (Ge
et al., 2014; Gjini et al., 2015; Ko et al., 2011; Kunimoto et al.,
2012; Li et al., 2011b; Moran-Crusio et al., 2011; Quivoron
Figure 4. Normal Vasculature and Blood Flow in tet2/3DM Larvae
(A and B) WISH for the vascular marker kdrl at 31 hpf.
(C and D) WISH for vascular marker cdh5 at 31 hpf.
(E and F) WISH for the arterial marker efnb2a at 31 hpf.
(G and H) WISH for the blood-flow-dependent marker klf2a at 36 hpf.
Scale bars indicate 100 mM. See also Figure S3.
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et al., 2011; Shide et al., 2012; Solary et al., 2014). In genetic
models, loss of Tet2 eventually leads to an expansion of hemato-
poietic progenitor cells in the bone marrow and skewed myeloid
differentiation (Gjini et al., 2015; Ko et al., 2011; Li et al., 2011b;
Moran-Crusio et al., 2011). However, the long latency that pre-
cedes these phenotypes suggests secondary somaticmutations
may be a contributing factor. In contrast to these later hemato-
poietic phenotypes, we find that combined mutation of tet2/3
causes an early loss of definitive blood cells, resulting from
compromised HSC production. Importantly, abnormalities in
HSC development occurred in embryos that were morphologi-
cally quite normal and had normal expression of vascular
markers. The relatively normal development of tet2/3DM larvae
supports a specific role for tet2 and tet3 in regulating transcrip-
tion of the embryonic HSC developmental program rather than a
more generalized role in regulating global transcription.
Compared to tet1, both tet2 and tet3 transcripts are relatively
enriched in the DA of the developing zebrafish embryo (Ge et al.,
2014). This expression pattern provides a potential explanation
for the specific overlapping Tet2/3 requirements in HSC produc-
tion. Analysis of double-mutant larvae revealed a combined
requirement for tet2/3 in regulating Notch signaling in the hemo-
genic endothelium, suggesting a role for 5hmC in the specifica-
tion or early function of this tissue. Enrichment of 5hmC has been
reported at Notch receptor and ligand genes in other tissues,
but the functional significance of these changes has not been
determined (Terragni et al., 2014). Intriguingly, we find Notch
signaling to be relatively intact in other tissues of tet2/3DM larvae,
indicating that Tet2/3 are likely be involved in fine-tuning the
activation of this pathway in select cell types. Notch signaling
is essential for HSC development in vertebrates and has been
implicated in both specification of the dorsal aorta and down-
stream HSC production (Jagannathan-Bogdan and Zon, 2013;
Robert-Moreno et al., 2005). Tet2/3 appear to be dispensable
for Notch regulation of arterial specification, as we observe
normal expression of the arterial marker ephrinb2 in tet2/3DM
larvae. Instead, disruption in Notch signaling in the hemogenic
endothelium favors a select requirement for Tet2/3 in the regula-
tion of HSC specification. This model is consistent with the
downstream disruption of the gata2b/scl/runx1 transcriptional
network observed in tet2/3DM larvae and our observation that re-
introducing scl or gata2b mRNA can rescue HSC production in
double mutants. Notably, Notch regulation is dispensable for
scl expression during the primitive wave of hematopoiesis, which
is consistent with the normal scl expression observed in tet2/3DM
primitive erythrocytes (Burns et al., 2005; Kim et al., 2013).
Figure 5. Tet2/3 Are Required for HSC Emergence through the Endothelial to Hematopoietic Transition
(A and B) Merged images depicting GFP and mCherry labeling of the vasculature in Tg(kdrl:Ras-mCherry), Tg(kdrl:H2B-EGFP) transgenic larvae at 30 hpf.
(C) Number of EHT events detected between 30 and 46 hpf in tet2/3DM larvae and siblings. Numerical data are presented as the mean ± SEM.
(D) Number of fragmented nuclei observed in the DA of tet2/3DM larvae and their siblings between 30 and 46 hpf. Numerical data are presented as the
mean ± SEM.
(E) Sequences from Movie S1 documenting the stepwise emergence of an HSC from the DA of a sibling larva. For each time point, merged GFP and mCherry
images are shown. The yellow arrow indicates the cell undergoing EHT.
(F) Sequences fromMovie S2 documenting a cell undergoing nuclear fragmentation in the DA of a tet2/3DM larva. For each time point, merged GFP and mCherry
images are shown. The yellow arrow indicates the cell with nuclear fragmentation.
All scale bars indicate 30 mM. See also Movies S1 and S2.
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Collectively, these results uncover a requirement for Tet regu-
lation of 5hmC in the early function of the zebrafish hemogenic
endothelium. A deeper understanding of how HSC generation
is regulated in vivo is expected to facilitate the in vitro production
of HSCs for therapeutic purposes. Importantly, our results iden-
tify regulation of 5hmC as an additional variable to be considered
in the optimization of protocols for HSC differentiation from
pluripotent progenitors. This observation may be of particular
relevance given recent data highlighting the impact of cell culture
conditions on global 5hmC levels (Blaschke et al., 2013; Nestor
et al., 2015; Yin et al., 2013).
EXPERIMENTAL PROCEDURES
Zebrafish Husbandry
Zebrafish maintenance and breeding were conducted under full animal use
and care guidelines with approval by the institutional animal care and use com-
mittee. Zebrafish were raised under standard conditions at 28C.
TALEN Mutagenesis
TALEN sequences were selected using Targeter 2.0 software (Doyle et al.,
2012). TAL repeat assembly was achieved using the Golden Gate assembly
method, and assembled repeats were integrated into the GoldyTALEN
scaffold (Bedell et al., 2012; Cermak et al., 2011). Assembled vectors served
as templates for in vitro mRNA transcription using the T3 mMessage mMa-
chine kit (Ambion) according to manufacturer’s instructions. 50–100 pg
mRNA was injected into wild-type embryos at the one-cell stage. Details of
mutation recovery and genotyping can be found in Supplemental Experimental
Procedures.
5hmC Dot Blot
Genomic DNA was isolated from larvae at 5 dpf by phenol-chloroform extrac-
tion and ethanol precipitation. Following RNase treatment and denaturation,
serially diluted DNA was spotted onto nitrocellulose membranes. Cross-linked
membranes were incubated with 0.02% methylene blue to validate uniform
DNA loading. Membranes were blocked with 5% BSA and incubated with
anti-5hmC antibody (1:10,000; Active Motif) followed by a horseradish perox-
idase-conjugated antibody (1:15,000; Active Motif). Signal was detected using
the ECL Prime Detection Kit (GE).
Figure 6. Tet2/3 Regulate Expression of the gata2b/scl/runx1 Transcriptional Network in the Hemogenic Endothelium
(A and B) WISH for scl at 31 hpf.
(C and D) WISH for runx1 at 24 hpf.
(E and F) WISH for gata2b at 24 hpf.
(G and H) WISH for gata2a at 24 hpf.
(I and J) WISH for runx1 in the DA of mock-injected and sclb mRNA-injected tet2/3DM embryos at 36 hpf.
(K and L) WISH for runx1 in the DA of mock-injected and gata2b mRNA-injected sibling embryos at 36 hpf.
(M) Percent of tet2/3DM embryos with high runx1 expression following mock injection or injection with mRNA encoding Sclb (50 pg) or Gata2b (200 pg). Numerical
data are presented as the mean ± SEM.
Numbers in the lower right corner of images indicate the fraction of larvae with WISH labeling similar to the representative image. All scale bars indicate 50 mM.
See also Figure S4.
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WISH
WISHwas performed as described previously (Thisse and Thisse, 2008). For all
probes except gata2b, 10% dextran sulfate was added to the hybridization
buffer.
RNA Synthesis and Microinjection
The human TET3 vector used for mRNA production has been previously
described (Ko et al., 2013). The human TET2ORF corresponding to GenBank:
NM_001127208 was amplified from cDNA made from SH-SY5Y neuroblas-
toma cells. Following sub-cloning, the TET2 ORF was introduced into the
pEF1/V5-His vector (Invitrogen) to allow for in vitro transcription. Mutant
TET2 (H1382Y, D1384A) was generated using the QuikChange Lightning
Site-Directed Mutagenesis Kit (Agilent). pExpress-1-gata2b was purchased
from Transomic Technologies. For scl-b, RT-PCR-amplified scl-b cDNA with
sequence corresponding to GenBank: EF488003 was cloned into pCS2+.
Sequences of all clones were confirmed by conventional DNA sequencing.
In all cases, capped RNA was synthesized using mMessage mMachine
(Ambion) with Sp6 or T7 polymerase as appropriate to the vector. For each
experimental condition, mRNA was injected into at least 50 embryos derived
from tet2mk17/mk17, tet3mk18/+ intercrosses.
Time-Lapse Confocal Microscopy
Embryos were anesthetized with 0.02% tricaine and embedded in 0.5%
low-melt agarose. Embryos were scanned using a SP8 confocal microscope
(Leica) at 28.5C. Confocal z stacks were acquired every 7–10 min between
30 and 46 hpf. Approximately 25 planes were collected per time point at a
spacing of 3 mm. Data were analyzed using Imaris software and exported in
QuickTime. All confocal planes were sequentially analyzed to identify changes
in cell morphology consistent with EHT and to identify nuclear fragmentation
events.
Tp1:GFP Imaging and Quantification
Mounted samples were scanned using an SP8 confocal microscope (Leica)
using 403 water-immersion objective at 26 hpf. For each image, 60 planes
were captured at a spacing of 0.38 mm.Data were processed using Imaris soft-
ware and quantified using ImageJ.
Statistical Analysis
The Student unpaired 2-tailed t test was used for statistical analysis.
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Abstract
Hematopoietic stem cells (HSCs) are multipotent self-renewing precursors with the
capacity to differentiate into all adult blood cell lineages. HSC development is a highly
orchestrated process regulated by multiple transcription factors and signaling pathways.
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Emerging evidence suggests that epigenetic regulation is an additional essential compo-
nent of HSC development. Powerful genetic and imaging approaches, combined with
conservation of mammalian programs, have made zebrafish a prominent model for the
study of HSC production. This chapter summarizes approaches that have been used to
identify epigenetic regulators of HSC development in zebrafish and highlights additional
strategies that are likely to facilitate progress in this promising field.
INTRODUCTION
Hematopoietic stem cells (HSCs) are self-renewing precursors from which all adult
blood cell types are derived. The production of HSCs during embryonic develop-
ment is essential for the establishment of the adult blood system (Orkin & Zon,
2008). Transplantation of HSCs derived from bone marrow or cord blood is a true
stem cell therapy, used to restore the hematopoietic system in patients with diseased
or defective bone marrow. This important therapeutic application has raised signif-
icant interest in understanding the mechanisms that regulate the de novo production
and maintenance of HSCs in vivo.
The acquisition of cellular identity relies on a combination of genetic and epige-
netic information. Genetic information encodes the transcription factors and effector
genes that drive progenitor fate and differentiation. In contrast, epigenetic informa-
tion shapes the accessibility of transcription factors to DNA, providing a heritable
chromatin landscape that can direct or reinforce cell typeespecific transcription pro-
grams. Studies in mice, cell culture, and zebrafish have identified a number of tran-
scription factors and signaling pathways that are important for HSC development
(Jagannathan-Bogdan & Zon, 2013). However, much less is known about how epige-
netic regulation contributes to the production and maintenance of HSCs in the devel-
oping embryo. Zebrafish are well suited to addressing this topic. In this chapter, we
provide an overview of approaches that have been used to identify epigenetic regu-
lators of HSC development in zebrafish and we discuss additional strategies that may
accelerate progress in this field.
1. MECHANISMS OF EPIGENETIC REGULATION
Epigenetic mechanisms control the accessibility of transcription factors to DNA
through the manipulation of chromatin structure. A principle component of chro-
matin is the nucleosome, which consists of a segment of DNA wound around a
core histone octamer. Covalent modifications of DNA and histone tails provide
two mechanisms to regulate chromatin compaction; these modifications contribute
to a heritable landscape that can influence recruitment of transcriptional machinery
through short- and long-range interactions at cis-regulatory regions.
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1.1 5-METHYLCYTOSINE
In vertebrate genomes, DNA can be modified through methylation of cytosine res-
idues (5-methylcytosine, 5mC). DNA methylation is associated with transcriptional
repression and is required for normal development (Goll & Bestor, 2005). The
methylation reaction is executed by two groups of DNA methyltransferases: the
maintenance methyltransferase, Dnmt1, and the de novo methyltransferases of the
Dnmt3 family. De novo methyltransferases methylate unmodified DNA to establish
methylation patterns. During maintenance of DNA methylation, the cofactor Uhrf1
recruits Dnmt1 to hemimethylated CpG dinucleotides at the replication fork, allow-
ing faithful propagation of methylation patterns to the newly synthesized DNA
strand (Bostick et al., 2007; Sharif et al., 2007). The zebrafish genome encodes sin-
gle well-conserved orthologs of Dnmt1 and Uhrf1. During the first 2 days of devel-
opment, uhrf1- and dnmt1-mutant zebrafish larvae appear overtly normal and
genome-wide methylation patterns are largely unaffected, perhaps due to significant
maternal deposition of mRNA encoding Dnmt1 and Uhrf1 (Chu et al., 2012; Martin,
Laforest, Akimenko, & Ekker, 1999). However, homozygous mutations in either
gene result in reduced genome-wide levels of DNA methylation and larval lethality
by 7 days post fertilization (dpf) (Anderson et al., 2009; Sadler, Krahn, Gaur, &
Ukomadu, 2007; Tittle et al., 2011). Mammalian genomes encode two de novo
DNA methyltransferases (Dnmt3A and Dnmt3b), whereas the zebrafish genome en-
codes six Dnmt3 orthologs (Goll & Halpern, 2011; Shimoda, Yamakoshi, Miyake, &
Takeda, 2005; Smith, Dueck, Mhanni, & McGowan, 2005). Mutations in individual
zebrafish dnmt3 genes have not been uncovered in forward genetic screens. It is
possible that functional redundancies among these genes have prevented their detec-
tion using unbiased approaches.
1.2 5-HYDROXYMETHYLCYTOSINE
While the mechanisms that establish and maintain DNA methylation are well stud-
ied, the pathways that regulate removal of 5mC have been more elusive (Wu &
Zhang, 2011). In 2009, the Tet proteins (Tet1, Tet2 and Tet3) were identified as a
family of cytosine dioxygenases that are capable of converting 5mC to 5-hydroxyme-
thylcytosine (5hmC) and its derivatives 5-formylcytosine and 5-carboxylcytosine
(He et al., 2011; Tahiliani et al., 2009). Conversion of 5mC to 5hmC and its deriva-
tives appears to drive DNA demethylation through the active excision or passive dilu-
tion of oxidized bases (Wu & Zhang, 2011). Tet-mediated DNA demethylation
provides one mechanism for reactivation of genes that have been transcriptionally
silenced by 5mC. It is also possible that in some contexts 5hmC may act as a unique
DNA modification that imparts distinct epigenetic information on the underlying
genome. The zebrafish genome encodes single orthologs of Tet1, Tet2, and Tet3,
and combinatorial mutation of these three genes reduces 5hmC in total genomic
DNA to levels below the threshold for antibody detection (Almeida et al., 2012;
Li et al., 2015).
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1.3 HISTONE MODIFICATION
The tails of individual histones within nucleosome are also subject to a variety of co-
valent modifications that regulate chromatin compaction (Bannister & Kouzarides,
2011). Histone tails are well conserved between zebrafish and other species and
the zebrafish genome encodes orthologs of many histone-modifying enzymes iden-
tified in mammals. Among the most well-studied histone tail modifications are his-
tone acetylation and methylation. Histone acetylation is regulated by the antagonistic
action of histone acetyltransferases and deacetylaces. Acetylation is generally asso-
ciated with open chromatin structure and active gene expression, whereas histone
deacetylation is correlated with gene repression (Eberharter & Becker, 2002).
Histone methylation represents a more complex level of regulation as residues can
be mono-, di-, or trimethylated and methylation can facilitate gene activation or
repression depending on which histone tail residues are modified and to what degree.
Polycomb and trithorax complexes represent two groups of proteins that are impor-
tant for the regulation of histone tail methylation. Trithorax group proteins are impor-
tant mediators of H3K4 di- and trimethylation, marks typically associated with
transcriptional activation (Schuettengruber, Chourrout, Vervoort, Leblanc, & Cavalli,
2007). In contrast, polycomb group proteins of the PRC2 complex are responsible for
trimethylation of H3K27, a mark of transcriptional inactivation. H3K27me3 further
mediates the recruitment of a second polycomb complex, PRC1, which monoubiqui-
tinates histone H2A on lysine 119 and stabilizes the repressive chromatin state
(de Napoles et al., 2004; Wang et al., 2004).
2. HEMATOPOIETIC STEM CELL DEVELOPMENT
As for all vertebrate species, the earliest hematopoietic cells in zebrafish represent
“primitive” lineages that support embryonic development but are derived from rela-
tively short-lived progenitors that are eventually replaced by HSC-derived cells
(de Jong & Zon, 2005). At the molecular level, early HSC development is regulated
by a core set of transcription factors including scl, gata2, and runx1 (Jagannathan-
Bogdan & Zon, 2013). Upstream of these factors, inputs from major signaling path-
ways including Bmp, Wnt, and Notch contribute to HSC development (Clements &
Traver, 2013). In mammals, a major site where HSCs are born is the aorta-gonad-
mesonephros region. Within this region, nascent HSCs emerge from a specialized
subset of endothelial cells within the dorsal aorta through a process termed the
endothelial-to-hematopoietic transition (EHT). During this process, cells of the
hemogenic endothelium transition to a hematopoietic fate in the absence of cell di-
vision (Bertrand et al., 2010; Boisset et al., 2010; Kissa & Herbomel, 2010). Later,
these cells migrate to the fetal liver and eventually to the bone marrow. Evidence
suggests that the de novo production of HSCs only occurs during a defined window
in the embryo, and self-renewing divisions of this initial pool provide for the expan-
sion and maintenance of HSCs through adulthood (Chen, Yokomizo, Zeigler,
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Dzierzak, & Speck, 2009; Go¨thert et al., 2005). Although more challenging than in
vitro approaches, the exquisite spatial and temporal regulation of this process makes
the in vivo study of HSC development important.
The rapid development of the hematopoietic system combined with external
fertilization and larval clarity make zebrafish an appealing model for the in vivo
study of HSC development. In zebrafish, the earliest HSCs emerge from the ventral
wall of the dorsal aorta at around 30 h post fertilization (hpf) and HSC production
continues until roughly 48 hpf (Bertrand et al., 2010; Kissa & Herbomel, 2010).
Exploiting the ability to visualize the process in zebrafish embryos, recent studies
identified additional signals required for HSC birth, including Cxcl12 from
somite-derived endothelial cells (Nguyen et al., 2014), TNFa from primitive neutro-
phils (Espı´n-Palazo´n et al., 2014), and INF-g from the hemogenic endothelium itself
(Sawamiphak, Kontarakis, & Stainier, 2014). Following emergence, these newly
born HSCs rapidly enter the subaortic space and subsequently migrate either directly
to the thymus or to the caudal hematopoietic tissue. By 4 dpf, HSCs seed the kidney
marrow, which is the site of adult hematopoiesis in zebrafish (Jin, Xu, & Wen, 2007;
Murayama et al., 2006).
3. APPROACHES
The dramatic shift in transcriptional profiles that occurs during EHT is likely to
require significant changes in the chromatin landscape. However, our current under-
standing of how epigenetic regulation contributes to the production and early main-
tenance of HSCs is limited. The accessibility of early stages of HSC development
and large brood sizes makes zebrafish well suited to genetic approaches aimed at
identifying epigenetic regulators of HSC development. The application of forward
and reverse genetic approaches in zebrafish is beginning to unravel the relevant
epigenetic pathways. It is important to note that because HSCs are produced from
specialized cells within the dorsal aorta, vascular development and artery specifica-
tion are prerequisites for HSC emergence. In this chapter, we focus our discussion on
identified genes that impact early HSC development but do not overtly impair devel-
opment of the vascular system.
3.1 UNBIASED FORWARD GENETIC APPROACHES
Small size and large brood sizes make zebrafish amenable to unbiased genetic
screening approaches. Based on these strengths, several genetic screens have been
performed to identify zebrafish mutants with impaired HSC development (Burns
et al., 2009; Du et al., 2011; Liu et al., 2015). These screens were not designed to
specifically identify epigenetic regulators of HSC development; nonetheless, two
known chromatin modifiers were among the identified genes.
Burns et al. (2009) screened a collection of 194 zebrafish lines harboring retro-
viral insertions in known genes for reduced expression of the HSC marker c-myb.
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The histone deacetylase enzyme, hdac1 was identified as one of nine genes in this
collection that was required for HSC production. Epistasis analysis demonstrated
that hdac1 is required downstream of Notch signaling and arterial formation.
Expression of runx1, an essential regulator of EHT, was reduced in hdac1 mutants
and HSCs could be rescued by injection of mRNA encoding this transcription factor.
Although direct targets were not identified, these results suggest that hdac1 acts up-
stream or in parallel to runx1 to promote HSC specific transcriptional programs. The
identification of hdac1 in this retroviral screen provided a first indication that epige-
netic regulation of chromatin states contributes to the control of HSC emergence.
More recently, an N-ethyl-N-nitrosourea-based screen for genes that disrupt
c-myb expression identified a requirement for the DNA methyltranserase, dnmt1,
in the early maintenance of HSCs (Liu et al., 2015). Dnmt1 mutant larvae had
overtly normal vascular development and arterial specification, but exhibited a clear
reduction in c-myb expression along the dorsal aorta, attributed to a diminished ca-
pacity for HSC proliferation in the mutants. Consistent with this hypothesis, cebpa, a
transcription factor known to negatively regulate HSC proliferation, was upregu-
lated in the mutants, and combined mutation of cebpa and dnmt1 rescued expression
of HSC markers. Studies in mouse have also identified a requirement for Dnmt1 in
the self-renewal adult HSCs derived from the bone marrow, suggesting a conserved
role for 5mC in HSC maintenance at multiple developmental stages (Bro¨ske et al.,
2009; Trowbridge, Snow, Kim, & Orkin, 2009). It remains possible that Dnmt1 also
has roles in the de novo generation of HSCs that are masked by maternally deposited
mRNA in zebrafish dnmt1 mutants. Additional analysis of maternal/zygotic dnmt1
mutant embryos will be required to definitively address requirements for dnmt1 in
early steps of HSC production.
3.2 REVERSE GENETIC APPROACHES
Forward genetic screens provide a powerful approach to identify novel gene func-
tions and pathways. However, they can be labor intensive and screens to date
have not been specifically designed to identify epigenetic regulators of HSC devel-
opment. Reverse genetic approaches for targeted elimination of specific gene prod-
ucts offer an alternative strategy to directly test known epigenetic regulators for their
role in HSC development. Reverse genetic approaches also facilitate testing of gene
families for functionally overlapping requirements in HSC development. In zebra-
fish, antisense morpholinos that block translation or splicing of target mRNAs
have historically been used as the primary tool for reverse genetics (Bill, Petzold,
Clark, Schimmenti, & Ekker, 2009). An advantage of this approach is the ability
to rapidly assess gene function, including for more than one gene, in morpholino-
injected embryos. However, there has been growing concern over the potential for
nonspecific phenotypes in morphant embryos (Kok et al., 2014; Robu et al.,
2007). Genome-editing approaches have now emerged as an attractive alternative,
allowing for the selective mutation of any gene of interest within the zebrafish
genome (Bedell et al., 2012; Hwang et al., 2013).
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To date, several groups have provided data implicating polycomb and trithorax
group proteins in HSC development using antisense morpholinos. Depletion of
the PRC1 genes Bmi1/1b or Ring1b, led to decreased expression of the HSC markers
runx1 and c-myb in the dorsal aorta (Yu et al., 2012). Similarly, morpholino deple-
tion of the trithorax gene mll resulted in reduced expression of HSC markers (Wan,
Hu, Liu, Feng, & Xiao, 2011). However, rescue of HSCs by coinjection of mRNA
encoding wild-type proteins was not demonstrated for any of these morphants and
upstream defects in vascular development were not investigated, making it difficult
to definitively assess the specificity of these phenotypes. More recently, morpholino-
knockdown of the 5mC dioxygenase tet2 gene in zebrafish was reported to cause
reduced expression of the HSC marker c-myb (Ge et al., 2014). However, similar re-
ductions in c-myb expression were not observed in tet2 mutant zebrafish, which are
viable to adulthood and show no obvious defects in embryonic HSC production
(Gjini et al., 2015; Li et al., 2015).
A major advance for the zebrafish field has been the development of tools for the
targeted introduction of mutations. Transcription activator-like effector nucleases
(TALENs) (Cermak et al., 2011) and clustered, regularly interspaced short palin-
dromic repeats combined with CRISPR-associated proteins (CRISPR/Cas9) (Cong
et al., 2013; Mali et al., 2013) can now be used to direct double-strand breaks to spe-
cific genomic loci. The subsequent repair of these breaks by the nonhomologous end
joining machinery is error-prone and often introduces small insertions or deletions
into the targeted gene. Both TALENs and CRISPR/Cas9 systems have been success-
fully applied in zebrafish with high efficiency (Bedell et al., 2012; Hwang et al.,
2013).
Because genome-editing techniques are relatively new to the zebrafish system,
they have yet to be extensively exploited for the mutation of known epigenetic reg-
ulators. However, the potential of these approaches is illustrated by a recent study
identifying overlapping requirements for the 5mC dioxygenases Tet2 and Tet3 in
HSC emergence. Using TALENs, Li et al. generated catalytic loss of function al-
leles for each of the three zebrafish tet orthologs and systematically examined all
mutant combinations (Li et al., 2015). Mutation of either tet2 or tet3 alone caused
only modest reductions in 5hmC and was not associated with defective HSC devel-
opment. However, combinatorial mutation of tet2 and tet3 led to a greater than
30-fold reduction in genome-wide 5hmC levels and a significant reduction in the
number of successful EHT events observed by time-lapse confocal microscopy
(Fig. 1A and B). Mutation of tet2/3 did not affect vascular development or arterial
specification; however, Notch signaling in the hemogenic endothelium and the
downstream expression of the scl/gata2b/runx1 hematopoietic transcription factor
network was disrupted in the double mutants (Fig. 1C and D). The results of this
study uncover a requirement for Tet enzymes in the function of the hemogenic
endothelium and identify dynamic regulation of 5mC as a previously unappreciated
aspect of HSC production. The combinatorial requirement for Tets in HSC emer-
gence identified in this study is unlikely to have been detected using forward genetic
approaches.
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3.3 CANDIDATE SCREENS
Reverse genetic approaches provide a straightforward mechanism to evaluate the
role of known epigenetic regulators in HSC development. However, this strategy
is typically applied to one or a few genes with anticipated phenotypes. Candidate
screens essentially leverage advantages of both forward and reverse genetic ap-
proaches. A recent candidate screen for chromatin factors that regulate zebrafish
hematopoiesis substantially expanded the number of epigenetic regulators impli-
cated in HSC development. Screening of a panel of 425 morpholinos that depleted
proteins containing amino acid motifs associated with chromatin or nucleic acid
binding revealed 31 candidates that caused strong alterations in runx1/c-myb expres-
sion levels (Huang et al., 2013). Among these candidates, 20 morpholinos impacted
HSC development without negative effects on vascular or arterial development
(Tables 1 and 2). Consistent with previous studies, this candidate screen implicated
hdac1 and components of the PRC1 and SET1/trithorax complexes in HSC produc-
tion. In addition, several genes that had not been previously implicated in HSC
development were uncovered, including brd8a, jmjd1, and nap1l4a. An added
advantage of the large scaleecandidate approach is that it allows for identification
FIGURE 1 Tet2/3 are required for hematopoietic stem cell emergence and Notch signaling in
the hemogenic endothelium.
(A, B) Time-lapse confocal images of Tg(kdrl:Ras-mCherry), Tg(kdrl:H2B-EGFP) tet2/3DM
(double mutant), and control siblings from 30 to 46 hpf. The yellow arrow indicates a cell that
has just completed endothelial-to-hematopoietic transition in a sibling larva (A) and a cell
undergoing nuclear fragmentation in a tet2/3DM larva (B).
DA indicates the dorsal aorta. AV indicates the axial vein. Scale bars indicate 30 mM.
(C, D) Images of Tg(tp1:GFP) tet2/3DM and control siblings at 26 hpf. DDA indicates the
dorsal wall of the dorsal aorta. VDA indicates the ventral wall of the dorsal aorta. Scale bars
indicate 60 mM. (See color plate)
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Table 1 Epigenetic Regulators With Known Requirements for Hematopoietic Stem Cell Development
Pathway Gene Gene Function
Mutant or
Morphant Rescue References
DNA
methylation
dnmt1 DNA methyltransferase Mutant Yes Liu et al. (2015)
tet2 Methylcytosine dioxygenase Morphant Yes Ge et al. (2014)
tet2; tet3 Methylcytosine dioxygenase Mutant Yes Li et al. (2015)
Polycomb
regulation
bmi1 Polycomb repressive complex 1 Morphant No Yu et al. (2012)
ring1b Polycomb repressive complex 1 Morphant No Yu et al. (2012)
cbx6b Polycomb repressive complex 1 Morphant No Huang et al. (2013)
cbx8b Polycomb repressive complex 1 Morphant No Huang et al. (2013)
Histone
methylation
mll SET1 histone methyltransferase complex Morpahnt No Wan et al. (2011)
ash2l SET1 histone methyltransferase complex Morphant No Huang et al. (2013)
cxxc1I SET1 histone methyltransferase complex Morphant No Huang et al. (2013)
setd1ba SET1 histone methyltransferase complex Morphant No Huang et al. (2013)
prdm12 Histone methyltransferase Morphant No Huang et al. (2013)
prdm16 Histone methyltransferase Morphant No Huang et al. (2013)
Histone
deacetylation
hdac1 Histone deacetylase Mutant No Burns et al. (2009)
hdac1 Histone deacetylase Morphant No Huang et al. (2013)
hdac6 Histone deacetylase Morphant No Huang et al. (2013)
hdac9a Histone deacetylase Morphant No Huang et al. (2013)
sirt7 Histone deacetylase Morphant No Huang et al. (2013)
Chromatin
remodeling
smarcd1 SWI/SNF chromatineremodeling complex Morphant No Huang et al. (2013)
smarcd2 SWI/SNF chromatineremodeling complex Morphant No Huang et al. (2013)
nap1l4a Nucleosome assembly factor Morphant No Huang et al. (2013)
brd8a Bromodomain-containing protein Morphant No Huang et al. (2013)
Histone
acetylation
p300 p300/CBP transcriptional coactivator complex Morphant No Huang et al. (2013)
3
.
A
p
p
ro
a
c
h
e
s
4
3
9
Table 2 Zebrafish Morphants That Cause an Expansion of Hematopoietic Stem Cell Populations
Pathway Gene Gene Function
Mutant or
Morphant Rescue References
Chromatin
remodeling
cecr2 Bromodomain-containing protein Morphant No Huang et al. (2013)
chd7 Chromodomain helicase DNAebinding protein Morphant No Huang et al. (2013)
Histone acetylation crebbpa CREB-binding protein Morphant No Huang et al. (2013)
Unknown mbd6 Methyl-CpG-binding protein Morphant No Huang et al. (2013)
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of multisubunit complexes that include more than one gene implicated by the screen.
This analysis revealed likely requirements for the SWI/SNF, ISWI, SET, and HAT
complexes in regulating HSC development. The advent and adaptation of Crispr/
Cas9 in zebrafish now allows for larger candidate screens that can overcome limita-
tions of high cost and nonspecific effects encountered with morpholinos (Shah,
Davey, Whitebirch, Miller, & Moens, 2015). This approach can be used to further
evaluate epigenetic components in HSC development.
4. DISEASE MODELS
There is strong evidence that disruption of the chromatin environment contributes to
malignancies of the hematopoietic system, including both myeloid (Shih, Abdel-
Wahab, Patel, & Levine, 2015) and lymphoid (Jiang & Melnick, 2015) malig-
nancies. Parallels between the hematopoietic system in humans and zebrafish
have inspired the use of zebrafish to model human leukemia (White, Rose, &
Zon, 2013). In particular, efforts to model myeloid malignancies, a class of clonal
diseases arising in hematopoietic stem or progenitor cells, have revealed new in-
sights into how epigenetic mechanisms promote normal and diseased states.
In humans, the NUP98-HOXA9 (NHA9) fusion oncogene is detected in high-risk
acute myeloid leukemia. This oncogene results from a chromosomal translocation
that fuses nucleoporin 98 kDa (NUP98) to homeobox A9 (HOXA9) (Nakamura
et al., 1996). In zebrafish, expression of the NAH9 fusion protein from a transgenic
pu.1 promoter causes fish to develop myeloproliferative neoplasms in adulthood
(Forrester et al., 2011). This same fusion also causes overproduction of HSCs in
the zebrafish embryo (Deveau et al., 2015). Microarray analysis revealed that the
DNA methyltransferase, dnmt1, is one of the most upregulated genes in embryos
expressing NHA9 (Deveau et al., 2015). Moreover, chemical inhibition of Dnmt1
by the DNA methyltransferase inhibitor decitabine rescued overproduction of
HSCs in embryos carrying the NHA9 transgene, suggesting that Dnmt1 overexpres-
sion plays a causative role in promoting HSC expansion. This observation is consis-
tent with the role for dnmt1 in HSC proliferation that was reported by Liu et al.
(2015). Intriguingly, combining sub-monotherapeutic doses of the histone deacety-
lase inhibitor valproic acid and decitabine also blocked the effects of NHA9 on
zebrafish blood development. These results link expression of the NAH9 fusion to
changes in the chromatin landscape and highlight the potential of combinatorial
epigenetic therapies in the treatment of NHA9-induced myeloid disease.
More recently, the first zebrafish cancer model driven by mutation of a known
chromatin regulator was described (Gjini et al., 2015). Mutations in the 5mC diox-
ygenase TET2 are detected with high frequencies in human myeloid malignancies
and mutations in Tet2 cause similar malignancies in mouse (Delhommeau et al.,
2009; Ko et al., 2011; Li et al., 2011; Moran-Crusio et al., 2011). As previously dis-
cussed, homozygous mutation of tet2 does not impact HSC development in the
zebrafish embryo. However, as they age, tet2 mutant zebrafish adults develop
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progressive clonal myelodysplasia, culminating in myelodysplastic syndromes by
24 months. Decreases in the modified base 5hmC were observed in hematopoietic
cells of the kidney marrow of tet2 mutants but not in other cell types, suggesting
that other Tet family members may compensate for tet2 outside of the hematopoietic
system. The lack of Tet redundancy in HSCs provides one likely explanation for the
high oncogenic potential of TET2 mutation in myeloid malignancies. Because tet2
mutants are viable and fertile, they provide a powerful model to dissect the pathways
that are regulated by Tet2 in the adult hematopoietic system. In addition, tet2mutant
embryos offer an opportunity for small-molecule screens to identify compounds that
selectively kill tet2 mutant HSCs. Such compounds may have therapeutic potential
for the treatment of myeloid malignancies.
5. CURRENT CHALLENGES AND FUTURE DIRECTIONS
To date, genetic approaches in zebrafish have implicated a number of important
epigenetic pathways in the regulation of HSC development. However, the generation
of additional tools and approaches will be required to fully realize the potential of
the zebrafish system.
5.1 TOOLS FOR UNBIASED SCREENING OF EPIGENETIC STATES
IN VIVO
To date, screens for regulators of HSC development in zebrafish have relied on
expression of HSC associated markers, leading to identification of a broad spectrum
of genes with diverse functions. More narrowly focused screens for epigenetic reg-
ulators of HSC development have not been performed, likely due to the lack of tools
to rapidly monitor epigenetic changes at the enhancers or promoters of relevant he-
matopoietic genes. Tools to monitor DNA methylation changes in zebrafish using
fluorescent reporters under the control of the yeast Gal4/UAS system have previ-
ously been described (Akitake, Macurak, Halpern, & Goll, 2011; Goll, Anderson,
Stainier, Spradling, & Halpern, 2009). However, the use of exogenous UAS
sequences to monitor DNA methylation makes this approach better suited for the
identification of global regulators of chromatin, rather than to those involved in a
particular developmental process.
A recently described variation on the Gal4/UAS approach has the potential to be
adapted for screening in zebrafish. The minimal Snrpn gene promoter is a methyl-
ation-sensitive promoter that is influenced by the DNA methylation status of
adjacent sequences. By placing this promoter upstream of a fluorescent reporter,
Stelzer and colleagues were able to visually track methylation changes at nearby
enhancer sequences in mouse embryonic stem cells based on fluorophore expression
(Stelzer et al., 2015). Placing the Snrpn reporter adjacent to enhancers of hematopoi-
etic transcription factors could provide one approach to monitor the methylation sta-
tus of HSC-specific enhancers in the developing zebrafish embryo. If successful, this
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approach would allow for unbiased screens specifically designed to identify genes
involved in the epigenetic control of the HSC transcriptional program.
5.2 TOOLS FOR TISSUE-SPECIFIC MUTATION
Another major challenge is that current approaches have relied on whole embryo
depletion of gene products. However, many epigenetic regulators are likely to be
important in multiple tissues and mutant embryos may not survive long enough
for analysis of HSC development. In other cases, upstream defects in mesoderm
patterning, vascular development, or arterial identify may mask later specific re-
quirements for epigenetic regulators in HSC development. These challenges will
require the use of tissue-specific approaches for mutation of candidate genes. The
Cre/loxP system has been widely used in mouse for the conditional mutation of spe-
cific genes (Nagy, 2000). This system is also functional in zebrafish (Hans, Kaslin,
Freudenreich, & Brand, 2009; Langenau et al., 2005). A recently described CRISPR/
Cas-based vector system that enables tissue-specific gene inactivation in zebrafish
provides one exciting alternative that could be applied to test a large number of
candidate epigenetic regulators for their requirements in HSCs or their endothelial
precursors (Ablain, Durand, Yang, Zhou, & Zon, 2015).
CONCLUSIONS
It is perhaps not surprising that epigenetic regulation plays a major role in HSC gen-
eration, as the transition from endothelial to hematopoietic identity represents a dra-
matic reprogramming of fate. The accessibility of zebrafish embryos from the time
of fertilization, coupled with larval clarity and large brood sizes has facilitated the
discovery of signals and genes that regulate the generation of HSCs. Identifying
mechanisms to manipulate HSC fate and proliferation has important implications
for the development of therapeutics to treat hematopoietic disorders. The transla-
tional potential of the zebrafish system is exemplified by the development of a
PGE2 derivative as a drug to expand transplantable HSCs from human cord blood.
A chemical screen identified the capacity of PGE2 for impacting production of
zebrafish HSCs (North et al., 2007), and within a few years the concept was being
tested in human clinical trials (Hagedorn, Durand, Fast, & Zon, 2014). In addition
to chemical screens, and the genetic strategies described above, new gene-editing
techniques offer opportunities to build zebrafish models for hematopoietic disease.
For example, mutations in genes known to be associated with leukemia, including
patient-specific alleles, can be created and combined with tet2 mutations to investi-
gate the impact on myeloid dysplasia. While the DNA and chromatin modification
machineries that are key to HSC biology are now beginning to be defined, the next
challenges will be to understand their target genes and to distinguish epigenetic
marks that are drivers of HSC phenotype from those that are consequences of altered
transcription. Again, emerging technologies provide exciting avenues of inquiry,
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limited only by investigators’ imagination. For example, modified Crispr/Cas9 tech-
nologies can now be developed to target not only mutations, but epigenetic modifi-
cations (Hilton et al., 2015; Maeder et al., 2013).
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